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Background: Whether or not clinically implementable exercise interventions in haemodialysis patients
improve quality of life remains unknown.
Objectives: The PEDAL (PrEscription of intraDialytic exercise to improve quAlity of Life in patients with
chronic kidney disease) trial evaluated the clinical effectiveness and cost-effectiveness of a 6-month
intradialytic exercise programme on quality of life compared with usual care for haemodialysis patients.
Design: We conducted a prospective, multicentre randomised controlled trial of haemodialysis patients
from five haemodialysis centres in the UK and randomly assigned them (1 : 1) using a web-based
system to (1) intradialytic exercise training plus usual-care maintenance haemodialysis or (2) usual-care
maintenance haemodialysis.
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Setting: The setting was five dialysis units across the UK from 2015 to 2019.
Participants: The participants were adult patients with end-stage kidney disease who had been
receiving haemodialysis therapy for > 1 year.
Interventions: Participants were randomised to receive usual-care maintenance haemodialysis or
usual-care maintenance haemodialysis plus intradialytic exercise training.
Main outcome measures: The primary outcome of the study was change in Kidney Disease Quality
of Life Short Form, version 1.3, physical component summary score (from baseline to 6 months).
Cost-effectiveness was determined using health economic analysis and the EuroQol-5 Dimensions,
five-level version. Additional secondary outcomes included quality of life (Kidney Disease Quality
of Life Short Form, version 1.3, generic multi-item and burden of kidney disease scales), functional
capacity (sit-to-stand 60 and 10-metre Timed Up and Go tests), physiological measures (peak oxygen
uptake and arterial stiffness), habitual physical activity levels (measured by the International Physical
Activity Questionnaire and Duke Activity Status Index), fear of falling (measured by the Tinetti Falls
Efficacy Scale), anthropometric measures (body mass index and waist circumference), clinical measures
(including medication use, resting blood pressure, routine biochemistry, hospitalisations) and harms
associated with intervention. A nested qualitative study was conducted.
Results: We randomised 379 participants; 335 patients completed baseline assessments and
243 patients (intervention, n = 127; control, n = 116) completed 6-month assessments. The mean
difference in change in physical component summary score from baseline to 6 months between
the intervention group and control group was 2.4 arbitrary units (95% confidence interval –0.1 to
4.8 arbitrary units; p = 0.055). Participants in the intervention group had poor compliance (49%)
and very poor adherence (18%) to the exercise prescription. The cost of delivering the intervention
ranged from £463 to £848 per participant per year. The number of participants with harms was
similar in the intervention (n = 69) and control (n = 56) groups.
Limitations: Participants could not be blinded to the intervention; however, outcome assessors were
blinded to group allocation.
Conclusions: On trial completion the primary outcome (Kidney Disease Quality of Life Short Form,
version 1.3, physical component summary score) was not statistically improved compared with usual
care. The findings suggest that implementation of an intradialytic cycling programme is not an effective
intervention to enhance health-related quality of life, as delivered to this cohort of deconditioned
patients receiving haemodialysis.
Future work: The benefits of longer interventions, including progressive resistance training, should be
confirmed even if extradialytic delivery is required. Future studies also need to evaluate whether or not
there are subgroups of patients who may benefit from this type of intervention, and whether or not
there is scope to optimise the exercise intervention to improve compliance and clinical effectiveness.
Trial registration: Current Controlled Trials ISRCTN83508514.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health
Technology Assessment programme and will be published in full in Health Technology Assessment;
Vol. 25, No. 40. See the NIHR Journals Library website for further project information.
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Although the benefits of exercise in the general population are well recognised, we do not know ifoffering cycling exercise during haemodialysis is an effective way to improve quality of life, and if this
would be a cost-effective way to provide exercise training for this patient population. To determine whether
or not this type of exercise training is effective, and provides value for money, this study compared cycling
during haemodialysis treatment, three times per week for 6 months, with usual care that does not include
routine delivery of any exercise training. Five regions of the UK were included in the study.We compared
the results from the two groups at the start of the study and at 6 months, after correcting for age and
diabetes status.We also assessed the economic impact of delivering the cycling during haemodialysis
programme and interviewed people from different regions of the UK in both groups.
The baseline assessments revealed a deconditioned population in the study. There was no difference
in quality of life or any physical function measures between the group that performed cycling during
haemodialysis and the usual-care group. Compliance with the exercise intervention was very poor.
Interviews with patients showed that patient engagement with the exercise training was linked to the
presence of an exercise culture, and leadership to provide this, in the renal unit. An economic evaluation
showed that delivering cycling during haemodialysis would not be value for money when delivered to
a deconditioned haemodialysis population.Ways to engage patients with exercise training during their
haemodialysis treatment should be explored further.
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Whether or not clinically implementable exercise interventions in haemodialysis patients improve
quality of life remains unknown. The PEDAL (PrEscription of intraDialytic exercise to improve quAlity of
Life in patients with chronic kidney disease) trial evaluated the clinical effectiveness and cost-effectiveness
of a 6-month intradialytic exercise programme on quality of life compared with usual care for
haemodialysis patients.
Design
We conducted a prospective, multicentre randomised controlled trial of haemodialysis patients from
five haemodialysis centres in the UK and randomly assigned them (1 : 1) using a web-based system
to (1) intradialytic exercise training plus usual-care maintenance haemodialysis or (2) usual-care
maintenance haemodialysis.
Setting
The setting was five dialysis units across the UK from 2015 to 2019.
Participants
The participants were adult patients with end-stage kidney disease who had been receiving
haemodialysis therapy for > 1 year.
Interventions
Participants were randomised to receive usual-care maintenance haemodialysis or usual-care
maintenance haemodialysis plus intradialytic exercise training.
Main outcome measures
The primary outcome of the study was change in Kidney Disease Quality
of Life Short Form, version 1.3, physical component summary score (from baseline to 6 months).
Cost-effectiveness was determined using health economic analysis and the EuroQol-5 Dimensions,
five-level version. Additional secondary outcomes included quality of life (Kidney Disease Quality
of Life Short Form, version 1.3, generic multi-item and burden of kidney disease scales), functional
capacity (sit-to-stand 60 and 10-metre Timed Up and Go tests), physiological measures (peak oxygen
uptake and arterial stiffness), habitual physical activity levels (measured by the International Physical
Activity Questionnaire and Duke Activity Status Index), fear of falling (measured by the Tinetti Falls
Efficacy Scale), anthropometric measures (body mass index and waist circumference), clinical measures
(including medication use, resting blood pressure, routine biochemistry, hospitalisations) and harms
associated with intervention. A nested qualitative study was conducted.
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Results
We randomised 335 patients: 175 to the exercise training group and 160 to the usual-care group;
243 patients (intervention, n = 127; control, n = 116) repeated the 6-month evaluations. A median of
47% (interquartile range 28–77%) of exercise training sessions were completed by patients in the exercise
training group at 6 months. The physical component summary score increased from 33.9 arbitrary units
(10.6 arbitrary units) to 34.8 arbitrary units (standard deviation 11.6 arbitrary units) in the intervention
group and reduced from 32.9 arbitrary units (standard deviation 11.3 arbitrary units) to 31.8 arbitrary
units (standard deviation 11.3 arbitrary units) in the control group. The mean difference in the change
in physical component summary score from baseline to 6 months between the intervention and control
groups was 2.4 arbitrary units (95% confidence interval –0.1 to 4.8 arbitrary units; p = 0.055). There were
no statistically significant changes in any objectively measured or physiological outcomes. A moderate
relationship existed between compliance (percentage of expected sessions completed) and both physical
component summary score change (Pearson’s r = 0.5; p = 0.02) and peak oxygen uptake change (Pearson’s
r = 0.2; p = 0.03). The cost of delivering the intervention ranged from £463 to £848 per patient per year.
The number of patients with harms (serious adverse events) was similar in the intervention group (n = 69)
and control group (n = 56).
Discussion
The PEDAL intradialytic exercise programme did not statistically improve Kidney Disease Quality of Life
Short Form, version 1.3, physical component summary scores sufficiently to meet the primary end point
of this study. Patient interviews revealed that patient engagement was related to the presence of an
exercise culture, and leadership to provide this, in the renal unit. Future work should evaluate methods
to improve patient engagement to enhance future studies and facilitate clinical implementation.
Trial registration
This trial is registered as ISRCTN83508514.
Funding
This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 25, No. 40.
See the NIHR Journals Library website for further project information.
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Chapter 1 Introduction
Parts of this report are reproduced or adapted with permission from Greenwood et al.1 This is anOpen Access article distributed in accordance with the terms of the Creative Commons Attribution
(CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: https://creativecommons.org/licenses/
by/4.0/. The text below includes minor additions and formatting changes to the original text.
Scientific background
Haemodialysis (HD) is a major treatment option for patients with end-stage kidney failure. Over
27,000 patients receive dialysis for chronic kidney disease (CKD) in the UK and 80% of these are
treated with HD.2 Improved dialysis techniques and management of co-existing disease have made
HD more tolerable, and many new patients can anticipate a longer life expectancy,3 although not
always with a good quality of life (QoL).
Both physical inactivity and impaired physical function are strongly associated with increased morbidity,
mortality and reduced QoL in patients on HD.3,4 Reduced QoL is also independently associated with
mortality in patients on HD. Reports indicate that Short Form questionnaire-36 items (SF-36) physical
component summary (PCS) scores of < 25 arbitrary units (AU) were associated with a 93% increased
risk of death and a 56% increased risk of hospitalisation in HD patients, and a 10-point decrease in PCS
score translated into a 25% increased risk of death within 2 years.5 Conversely, a 1-point increase in PCS
score was associated with a 3.5% improvement in the odds of death.6 Interventions designed to increase
physical function and reduce sedentary behaviour in patients on HD may mitigate cardiovascular disease
risk, improve physical functioning, improve fitness for potential future kidney transplantation, lower
levels of fatigue and, in turn, improve QoL. A non-randomised controlled trial (RCT) by Painter et al.7
reported an average 4-point increase in PCS score in the intervention group (in-centre intradialytic
cycling or individualised home exercise programme) and an average 6-point decrease in PCS score
in the non-intervention group. A study by DeOreo8 reported that for every increase in PCS score of
5 AU there is an ≈ 10% increase in the probability of survival.
Evidence from several systematic reviews9–22 indicates that a range of exercise training interventions
show potential to improve exercise capacity and physical function in patients with dialysis-dependent
CKD. The greatest effects were reported after 6 months of exercise and were associated with both
supervised exercise and higher intensities of exercise. However, most of the studies reviewed were
small trials, many of which were not methodologically robust, and non-intradialytic interventions were
occasionally included in the evidence synthesis.16 Relatively few of the reviewed studies on intradialytic
exercise training were appropriately powered to detect QoL outcomes, and none included a cost-
effectiveness analysis. Moreover, adverse events (AEs) in the published literature were recorded in
only a minority of studies17 or were poorly reported.16 A recent systematic review22 on intradialytic
exercise training suggests that aerobic and resistance exercise programmes, delivered alone, can
improve aerobic capacity, but that a combination of both can improve a greater range of outcomes,
including exercise capacity, depression and some elements of QoL. By contrast, a recent systematic
review by Young et al.18 indicated that there was insufficient evidence demonstrating whether or not
cycling exercise during HD improves patient outcomes. The recommendations emerging from these
systematic reviews indicated the need for (1) high-quality, adequately powered RCTs of intradialytic
exercise and (2) routine collection and reporting of AE data associated with participation in these trials.
The generation of this information may help to more fully identify recommendations for an exercise
delivery pathway for HD patients and, ultimately, its clinical implementation.21
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The PEDAL (PrEscription of intraDialytic exercise to improve quAlity of Life in patients with chronic kidney
disease) trial was designed in response to a National Institute for Health Research (NIHR)-commissioned
call to evaluate the clinical benefit and cost-effectiveness of exercise during HD (intradialytic exercise) in
patients with end-stage kidney disease. At the time of planning and developing the PEDAL trial (2012)
there was extremely limited evidence on the effectiveness of intradialytic cycling on patient-centred
outcomes such as QoL indices. In CKD stages 2–5, overall QoL was improved with exercise training.9
Improved scores in the self-reported physical function subscales of the questionnaires appeared to be
the main drivers for the overall improvement.9 Other elements of QoL, such as vitality, social function
and general health, did not show a systematic change.9 Short-term (2–6 months), structured and
supervised moderate-intensity aerobic training programmes (mainly cycling) have been reported to induce
a systematic and large improvement in cardiorespiratory fitness (VO2peak) of 17–50%, with an overall mean
difference between treatment and control groups of 5.22 ml/kg/minute. Such improvements exceed the
clinically important criterion of 1 metabolic equivalent (MET) (3.5 ml/kg/minute). Thus, we utilised the
evidence base promoting intradialytic cycling for improved cardiorespiratory fitness to investigate
whether or not the physiological benefits derived from cycling could extend to perceived enhanced QoL.
Furthermore, as inconsistent improvements have been noted for objectively measured functional capacity
indices (walking speed/distance, sit-to-stand 60 performance) from previous intradialytic cycling studies,
we chose to evaluate key secondary outcome measures of objective physical function.
The rationale for intradialytic exercise is both intuitively and pragmatically appealing because the
environment of unit-based HD provides a platform for longer-term sustainable implementation of
exercise rehabilitation programmes and, thus, could promote exercise-enhancing behaviours in HD
patients. The current requirement for HD patients to attend 4-hour HD sessions three times per week
provides a practical opportunity to deliver a structured and supervised rehabilitation programme with
an enhanced potential for participation, associated with a substantially reduced patient burden in
terms of time, effort and travel cost.
Objectives
Primary objective
The primary objective of this trial was to determine, in comparison with usual care, whether or not
usual care augmented by intradialytic exercise training for a period of 6 months improved Kidney
Disease Quality of Life Short Form, version 1.3 (KDQoL-SF), PCS score in stage 5 CKD patients
receiving maintenance HD.
Secondary objectives
The secondary objectives were to determine, in comparison to usual care, whether or not usual care
augmented by intradialytic exercise training improved:
l physical function and physical activity outcomes
¢ peak aerobic capacity




¢ resting blood pressure
¢ haemoglobin, serum phosphate and parathyroid hormone levels
¢ arterial stiffness [pulse wave velocity (PWV)].
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l anthropometric measures
¢ body mass index (BMI)
¢ waist and hip circumference.
l patient-reported outcomes
¢ QoL and symptom burden assessments [EuroQol-5 Dimensions, five level version (EQ-5D-5L)]
¢ habitual physical activity levels (International Physical Activity Questionnaire)
¢ Duke Activity Status Index
¢ falls confidence (Tinetti Falls Efficacy Scale).
Economic analysis of cost-effectiveness
l Quality-adjusted life-years (QALYs) derived from the EQ-5D-5L.
l Resource use associated with physiotherapy assistant time.
l Resource use associated with delivery of exercise programme.
l Equipment costs.
l Hospital admissions and medication use recorded (with consent) from the patient’s clinical records.
Qualitative study
l A nested, qualitative study investigating the experience and acceptability of the intervention for
both participants and members of the renal care team.
Harms
l Serious adverse events (SAEs).
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We conducted this prospective, multicentre RCT in five regions of the UK.
Ethics approval and research governance
The trial protocol was approved by the relevant health authorities and institutional review boards, and
all patients provided written informed consent. London Fulham Research Ethics Committee approved
the protocol (reference 14/LO/1851). The study was prospectively registered as ISRCTN83508514. An
independent data and safety monitoring committee performed regular safety surveillance. Data were
entered into an electronic case report form by the investigators and were analysed at the Robertson
Centre for Biostatistics, University of Glasgow.
Patient and public involvement
The planning and delivery of the PEDAL trial was facilitated by close engagement with people living with
CKD and utilising HD therapy. Patients contributed directly to both the development of trial materials
(e.g. participant information leaflets and consent forms) and the way the trial was conducted. INVOLVE
good practice guidelines23 were followed to ensure service-user leadership in the trial delivery and
dissemination of the findings. INVOLVE is a national advisory group established and funded by the NIHR to
support active public involvement in NHS, public health and social care research.23
Participants
Inclusion criteria
l Prevalent patients with stage 5 CKD receiving maintenance HD therapy for > 3 months who were
male or female, aged > 18 years and able to provide written informed consent.
Exclusion criteria
l Patients unlikely to be receiving HD for > 6 months (this includes cachectic patients and those with
severe heart failure (New York Heart Association Functional Classification ≥ 3)].
l Patients for whom dialysis withdrawal was being considered.
l Patients likely to receive a live donor transplant or be transferred to peritoneal dialysis in the
period of time.
l All patients within 3 months of initiation of HD. (Patients in this time frame are generally less
clinically stable, many having vascular access procedures performed, and have much higher rates of
intercurrent events, including death and hospitalisation).
l Patients deemed to be clinically unstable by their treating physician.
l Patients with bilateral lower-limb amputations.
l Patients with dementia or severe cognitive impairment, and other patients unable to give
informed consent.
l Patients with psychiatric disorders (who are not treated and stable).
l Patients who were pregnant.
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Screening and eligibility
The majority of potential participants for the PEDAL trial were identified during routine HD clinical
consultations and concurrent evaluation of clinical records to confirm eligibility for participation.
Patients already established on HD for > 3 months were eligible and easily identified from hospital
databases and dialysis logs. If considered eligible for the study, they were approached by a member of
the renal health-care team who discussed the study and provided them with a participant information
sheet with further details. After allowing the patient a minimum of 24 hours to read and consider the
information in the participant information sheet, and to consult with family members, the research
team approached the patient (usually during the next dialysis session) to answer any questions. If the
patient agreed to proceed, an appointment was made for familiarisation and baseline outcome
assessment sessions. Written informed consent was obtained by a member of the research team prior
to any study assessments.
Randomisation and blinding
Randomisation was conducted using a centrally controlled, web-based randomisation system run by
the Glasgow Clinical Trials Unit (GCTU). To ensure balanced assignment across critical variables, a
minimisation algorithm was employed, taking into account baseline age, sex and diabetes status. It was
impossible to blind the ‘treating’ physiotherapy assistants or the participants and, thus, the study
implemented a blinded outcome assessment and analysis.
Intervention
Intradialytic exercise training
The intradialytic exercise prescription was based on current physical activity guidelines for the elderly24
and for people with diabetes25 and cardiovascular disease.26 These recommend that a minimum target
amount of 1000 kcal per week is expended in physical activity for health benefits, with optimal benefits
associated with a weekly target physical activity accumulation of 1500–2000 kcal or at least 150 minutes
per week at moderate exercise intensity and at least 2 days per week of resistance-based training for
muscular endurance and strength gains. Because opportunity for structured, prescribed exercise was
largely restricted to patients’ 3 days of HD, the training aim was for patients to accumulate a level as close
as possible to or exceeding this minimum threshold level of 1500 kcal per week through intradialytic
exercise. A target overall volume of exercise was calculated in energy expenditure units (kcal per week)
using the frequency, intensity, time, type (FITT) principle and provided for all patients, with an individualised
progression plan towards this goal.
The following progression plan was devised as a general guide:
l Introductory/adoption phase: a minimum cycling duration of 21 minutes per dialysis session was
used as a starting point target. By the end of the first 4 weeks, all patients were expected to cycle
for 21 minutes either in two 10-minute bouts or continuously at the low end of the moderate
exercise intensity range.
The progression requirements were that, by week 8, all participants should be able to cycle for
≥ 21 minutes continuously on the cycle ergometer (63 minutes per week) at the low end of the
moderate exercise intensity range. The overall minimum target volume of exercise was set at
140 kcal per cycling session.
l Progression/adoption phase: expected to last 12–14 weeks. During these weeks, emphasis was
placed on progressing exercise stimulus mainly through duration. A reasonable and achievable
exercise target for this group would be a minimum cycling duration of 21–30 minutes per dialysis
session at moderate intensity. The overall minimum target volume of exercise was set at
1000–1200 kcal per week or ≈ 170 kcal per dialysis exercise session.
METHODS
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l Behaviour development phase: expected to last up to 24 weeks. All patients should be able to
achieve a target duration ranging from 30–40 minutes per dialysis session (90–120 minutes per
week) at moderate to vigorous exercise intensity (55–70% VO2reserve). The overall minimum target
volume of exercise was set at ≈ 1500 kcal per week (or ≈ 214 kcal per dialysis session) and this
would be achieved through adjustments to duration and intensity.
The prescribed individualised training intensity was derived from a peak aerobic capacity (VO2peak)
assessment, using a 1-minute ramp incremental protocol on a cycle ergometer. New exercise intensity
ranges were established at the 3-month follow-up assessment time point. Exercise prescription was set
at a workload corresponding to 40–75% of VO2reserve. We also made a note of rate of perceived exertion,
heart rate and blood pressure responses corresponding to these ranges of exercise intensity during the
incremental cycle testing protocol and used these indices to guide and monitor progression until the
next planned assessment point (3 months), at which time the exercise prescription was renewed.
Using a modified and custom-made Monark cycle ergometer (HaB International Ltd., Southam, UK),
aerobic exercise was performed, in a semi-recumbent position, three times per week during the first
2 hours of HD. Exercise duration and intensity were recorded and monitored for each exercise session
in exercise diaries. In addition, ratings of perceived exertion, BP and HR were recorded during the training
sessions. The energy expenditure goals were deliverable through a progressive increase in intradialytic
cycling from short bouts of 8–10 minutes to bouts of 21 minutes and bouts of 40 minutes or more, at the
prescribed exercise intensity, resulting in 55%, 69% and 75%, respectively, of the target weekly minimum
physical activity volume of 1000 kcal being achieved. Twice per week participants also completed lower-
extremity muscular conditioning exercise, using ankle weights, after aerobic cycling exercise. Physiotherapy
assistants (band 4 technical instructors) were employed in each region to deliver the intradialytic
intervention. This role, supervised and quality assured by a regional co-ordinator, involved the technical
implementation of the exercise prescription produced by the regional research assistant, who was
blinded to treatment allocation.
Usual care: haemodialysis therapy
Usual care was based on UK Renal Association guidelines for HD2 and included management of blood
pressure, treatment of anaemia, phosphate control and cardiovascular risk mitigation strategies. For
the purposes of the trial, we specified that usual care, in both arms of the trial, should allow all of
these treatments to continue unchanged so that we were investigating any additional benefit of the
intradialytic exercise training intervention compared with usual care.
Adherence
We attempted to minimise the loss to follow-up in this study by (1) emphasising to participants the
importance of their attendance at follow-up assessments even if they were no longer compliant with
the intervention, (2) reducing outcome assessment appointments to a maximum of two non-dialysis day
visits, (3) using a reminder protocol for non-dialysis day assessment appointments that utilised prompts
by the dialysis unit staff, letters and telephone contact, (4) providing travel remuneration (including,
where necessary, taxi costs), and (5) the provision of training in issues related to compliance for all
study staff who came into contact with the participants.
Primary and secondary outcomes
Primary outcome
The primary end point for this study was change in KDQoL-SF PCS score between baseline and
6 months. The KDQoL-SF is a disease-specific QoL measure that includes the SF-36 as a generic
core plus symptoms/problems of kidney disease scales. The SF-36 has 36 items compiled into
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eight scales: physical functioning, role functioning/physical, bodily pain, general health, vitality, social
functioning, role functioning/emotional and mental health. These scales are scored from 0 to 100 AUs;
a higher score is more positive (i.e. less pain or less limitation). Normalised scores representing overall
physical functioning and mental functioning are calculated from the individual scales and are presented
as PCS and mental component summary (MCS) scores. The PCS includes the dimensions of physical
functioning, role functioning/physical, bodily pain, general health, vitality and social functioning.
Secondary outcomes
Quality of life
A documented change in EQ-5D-5L score from baseline to 6 months is a key QoL secondary outcome.
Peak aerobic capacity
VO2peak was determined by an incremental cycling exercise tolerance protocol. Breath-by-breath gas
exchange was measured using cardiopulmonary exercise testing equipment calibrated prior to each
patient assessment. The exercise testing protocol started with a 3-minute unloaded cycle, followed by
ramp increases in resistance of 15 watts per min until one of the following occurred: (1) plateau in
oxygen uptake, (2) attainment of respiratory exchange ratio ≥ 1.15 or (3) patient request to stop.
Average oxygen uptake during the final 20 seconds of the test was recorded as the VO2peak.
Electrocardiogram and heart rate were continuously monitored, and blood pressure was recorded
every 1 or 2 minutes throughout the ramp incremental test. Rate of perceived exertion and angina
scale were recorded every minute for safety.
Physical performance tests
Patient physical function was assessed by the sit-to-stand 60 (STS60) test27 and the 10-metre Timed
Up and Go (10mTUG) test,28 both of which have been used as accurate and valid measures of lower-
leg strength, balance, co-ordination, gait speed and physical function in HD patients.
Anthropometric measures
Measures of height, body mass, BMI and waist circumference were performed.
Cardiovascular risk
Carotid–femoral PWV is considered the gold standard for non-invasive arterial stiffness assessment in
clinical practice29 and has been suggested as a surrogate cardiovascular end point. This was assessed
with the Vicorder® system (Skidmore Medical Limited, Bristol, UK). The Vicorder system is small,
portable, non-invasive and non-operator-dependant. In addition, it was available in all centres to ensure
comparability of the data. Conditions for assessment, as described in the expert consensus statement by
Laurent et al.,29 were adhered to for all measurements. The measurement protocol by Hickson et al.30 was
used, mathematically removing the additional femoral segment from the Vicorder standard protocol to
correct for any inherent bias at high arterial PWV. An average of three measurements (of 20 consecutive
signals) was recorded at each time point. Resting predialysis blood pressure was assessed.
Physical function, physical activity and fear of falling questionnaires
Patients completed the following questionnaires to capture data about physical activity, activities of
daily living and falls: the International Physical Activity Questionnaire Long Form,31 the Duke Activity
Status Index (a self-reported, 12-item questionnaire that assesses activities of daily living)32 and the
Tinetti Falls Efficacy Scale (measuring fear of falling).33
Blood tests
Clinical blood tests were collected pre dialysis and included haemoglobin, serum phosphate and
parathyroid hormone.
METHODS
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Medication
Dosages of erythropoiesis-stimulating agents were recorded.
Safety and monitoring of the intervention
Safety and monitoring data included discontinuation from the exercise intervention and permanent
study withdrawals with reasons, compliance with the exercise programme and adherence to the
exercise prescription and SAEs.
Engagement and fidelity to exercise prescription
General engagement with the exercise intervention was defined as the percentage of exercise sessions
completed of the total prescribed. Compliance was calculated as the number of sessions completed at
week 13 and 26 of the exercise programme divided by the number of expected sessions completed
(39 and 78 for weeks 13 and 26, respectively) and multiplied by 100. Acceptable compliance was defined
as > 70% compliance and poor compliance was defined as < 50% compliance. To monitor adherence
(fidelity) to exercise prescription in terms of intensity and volume of exercise achieved, data on duration
of cycling (excluding warm up and cool down), power output, number of sets and repetitions for muscle
conditioning exercises were recorded in individual participant exercise diaries for each exercise session.




A sample size calculation, based on an assumed difference of 4 AU in KDQoL-SF PCS score AU and a
standard deviation (SD) of 10 AU as seen in the study by Painter et al.,7 and conservatively comparing
6-month KDQoL-SF PCS scores between groups by two sample t-test (two-sided 5% significance level)
resulted in a sample size of 133 completers per group, with 83% power to detect a mean difference of
4 AU in KDQoL-SF PCS score. To allow for 30% loss to follow-up over 6 months, as seen in phase II
trials,25 190 participants per group were suggested to be randomised. This sample size calculation
did not take into account adjustment for baseline PCS scores. Subsequent analysis by the GCTU of
within-trial change in PCS score from baseline, adjusted for baseline levels and randomisation
minimisation variables, suggested that the study will have 80% power to detect a 4-point difference
with only 87 participants per group with complete data at baseline and 6-month follow-up. Likewise,
115 participants per group would be needed if a zero score is imputed for deaths prior to 6 months.
Key secondary outcome
Analysis of blinded within-trial data adjusting for baseline levels and randomisation minimisation
variables suggest that a study of 44 participants per group would have 90% power to detect the
minimum clinically important difference in peak aerobic capacity of 3.5 ml/kg/min (1 MET).
Statistical analyses
A full statistical analysis plan was signed off prior to database lock and study unblinding. Descriptive
statistics of clinical and sociodemographic variables at baseline are presented split by treatment group.
Primary outcome
The primary outcome measure (change from baseline to 6 months in KDQoL-SF PCS score) was
compared between the control and intervention groups using a normal linear model, adjusting for
baseline KDQoL-SF PCS score and the randomisation minimisation variables. The findings are presented
as the adjusted mean difference, with 95% confidence interval (CI), between the treatment groups.
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The main analysis was carried out on research participants with PCS assessments at baseline and at
6 months. Two sensitivity analyses were also carried out, first imputing a score of zero for those who
died prior to 6 months and, second, based on all participants with a baseline PCS score using the
method of multiple imputation.
Secondary outcomes
Other continuous outcomes were analysed as for the primary outcome.
Binary outcomes were compared between treatment groups using logistic regression models, adjusting
for baseline value. The results are reported as the adjusted odds ratio with 95% CI.
Time-to-event outcomes were calculated as time from randomisation and compared between
treatment groups using Cox proportional hazards regression models. The results are reported as the
adjusted hazard ratio for intervention versus control with 95% CI.
Data involving counts of events were compared between treatment groups using negative binomial
regression models, adjusting for length of follow-up. The results are reported as the adjusted treatment
effect with 95% CI.
Subgroup analyses
In the intervention group, the primary outcome was compared between those who had completed
< 30% of the expected exercise sessions, those who had completed ≥ 30% but < 50% of the expected
exercise sessions, those who had completed ≥ 50% but < 70% of the expected exercise sessions and
those who had completed ≥ 70% of the expected exercise sessions. This was done using a linear
regression model, predicting the primary outcome from the above categories for the expected exercise
sessions completed, adjusting for minimisation variables.
The primary outcome was also assessed, comparing the control group with the three completer groups
defined above. In addition, the relation of the percentage of sessions completed at 6 months follow-up
to the primary outcome were analysed in two ways:
1. as a linear regression predicting the primary outcome from the percentage of sessions completed at
6-month follow-up, adjusting for baseline PCS score and minimisation variables, in the intervention
group only
2. as a linear regression predicting the primary outcome from the percentage of sessions completed
at 6-month follow-up, adjusting for baseline PCS score and minimisation variables, in all patients,
setting the percentage of sessions completed to 0 in the control group.
Safety analyses
Discontinuations from the intervention and permanent study withdrawals and their reasons were
tabulated, as was adherence to the exercise prescription. SAEs were tabulated by system organ class
and body system.
Data monitoring and quality assurance
The trial was coordinated by a Trial Management Group (TMG), consisting of the chief investigator,
GCTU Assistant Director and senior clinical trial manager and a statistician. The trial manager
co-ordinated the study and was accountable to the chief investigator. The central trial office (King’s
College Hospital and GCTU) provided support to each site. The central trial office was responsible for
randomisation, collection of data in collaboration with the research co-ordinator, data processing and
analysis. Publication and dissemination of the study results was co-ordinated by the trial office in
collaboration with the chief investigator and investigators. A Trial Steering Committee was established
METHODS
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to oversee the conduct and progress of the trial. The study’s funder – the NIHR Health Technology
Assessment (HTA) programme – formally appointed the chairperson and members after the nominations
from the TMG. A charter was drawn up to describe membership, roles and responsibilities of the Trial
Steering Committee. The Independent Data Monitoring Committee was an independent group of
experts, consisting of a nephrologist, physiotherapist, lay member and a statistician, who monitored
patient safety and treatment efficacy data while the clinical trial was ongoing; the primary mandate of
this committee was to protect patient safety.
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Patient flow, including recruitment to and retention in the trial, is detailed in Figure 1. The trial recruited
prevalent patients with stage 5 CKD receiving HD therapy from June 2015 to June 2019 in five regional
kidney units in the UK. In total, the trial recruited 379 participants. A total of 335 participants attended a
baseline study visit: 175 participants who were randomised to the exercise intervention and 160 participants
who were randomised to usual care. Participants were informed of group allocation only after completing all
baseline assessments. Fifty-nine patients allocated to the exercise intervention and 60 participants allocated
to usual care did not complete the 6-month assessment. In total, seven participants died during the study:
three participants from the intervention group and four participants from the usual-care group. In the
intervention group, 40 participants were withdrawn and 16 did not attend for the final 6-month assessment.
In the usual-care group, 15 participants were withdrawn and 14 participants did not attend the 6-month
assessment. Participants were more likely to withdraw from the trial if they were older and female. Analysis
to establish how participants who withdrew differed from those who remained in the trial, stratified by arm,
did not reveal significant differences in age, sex or weight, but it does appear that participants were more
likely to drop out of the exercise arm if they had a history of heart failure and cerebrovascular disease
(Table 1). The primary outcome was therefore known for 243 (73%) participants who attended a baseline
visit: 116 (66%) participants in the intervention group and 127 (79%) participants in the usual-care group
(see Figure 1).
Demographic and other baseline characteristics
Baseline characteristics of randomised participants
Of the 335 randomised participants, 62.4% were male (see Table 1). The median age was 59.3 years
[interquartile range (IQR) 48.8–70.5 years]. Half of the randomised population was white and 34.3%
was black African/black Caribbean. The mean weight was 80.5 kg (SD 20.1 kg) and most participants
were classified as overweight or obese [median BMI of 27.8 kg/m2 (IQR 24.0–32.2 kg/m2)]. A total of
13% reported a musculoskeletal or orthopaedic condition, and participants had haemoglobin levels
of 100–120 g/l at baseline.
Prior cardiovascular events and risk factors
A history of major adverse cardiovascular events affected the minority of participants; prior stroke
and myocardial infarction were present in 8% and 12% of the cohort, respectively. A history of heart
failure or peripheral vascular disease was recorded for 4% and 10% of participants, respectively.
At baseline, 78% of participants had hypertension, 39% had diabetes, 21% had hyperlipidaemia and
58% had never smoked.
Adherence
A total of 175 participants received the exercise intervention. A median of 47% (IQR 28–77%) of
exercise training sessions were completed by participants in the intervention group at 6 months.
A total of 23% of participants had dropped out of the exercise intervention at 6 months, and 58% of
participants reported temporary cessation of the intervention. At 6 months, only 18% of participants
were adhering to the full exercise prescription (Table 2).
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• Did not meet inclusion criteria, n = 410
• Declined to participate, n = 650
• Other reasons (e.g. competing trials), n = 990
Did not attend baseline assessment
(n = 44)
• Died, n = 3
• Withdrawn, n = 41
• Transplanted, n = 8
• Participant decision, n = 23
• Physician recommendation, n = 7
• Adverse event, n = 2
• Moved away, n = 1
Participants randomly assigned who attended baseline visit
(n = 335)
Analysis
Allocated to normal routine care
(n = 160) 







Did not attend 6-month visit 
(n = 33)
• Died, n = 4
• Withdrawn, n = 15
• Adverse event attributed to the intervention, n = 0
• Adverse event not attributed to the
intervention, n = 1
• Participant decision, n = 4
• Physician recommendation, n = 1
• Moved away, n = 2
• Transplanted, n = 7
• Other, n = 0
• Unknown, n = 0
• Did not attend, n = 14
• Missed visit, n = 7
• Subsequently withdrawn due to participant
decision, n = 7
• Subsequently died, n = 0
Did not attend 6-month visit 
(n = 59)
• Died, n = 3
• Withdrawn, n = 40
• Adverse event attributed to the intervention,
n = 1
• Adverse event not attributed to the
intervention, n = 5
• Participant decision, n = 8
• Physician recommendation, n = 9
• Moved away, n = 1
• Transplanted, n = 13
• Other: initiated PD, n = 1; recruited to another
    study, n = 1
• Unknown, n = 1
• Did not attend, n = 16
• Missed visit, n = 4
• Subsequently withdrawn due to participant
decision, n = 5
• Subsequently died, n = 4
• Lost to follow-up, n = 3
Withdrawal
FIGURE 1 The PEDAL trial Consolidated Standards of Reporting Trials (CONSORT) diagram. Reproduced with permission
from Greenwood et al.1 This is an Open Access article distributed in accordance with the terms of the Creative Commons
Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial
use, provided the original work is properly cited. See: https://creativecommons.org/licenses/by/4.0/. The figure includes
minor additions and formatting changes to the original figure.
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TABLE 1 Baseline characteristics of all patients in the trial, stratified by group, according to withdrawal from the trial
Baseline characteristic
Group
Patients not withdrawn Patients withdrawn
Control Intervention Control Intervention
Age (years)
N 145 135 15 40
Mean (SD) 59.8 (14.1) 60.5 (15.0) 52.8 (19.9) 56.8 (13.3)
Median (Q1, Q3) 59.7 (50.5, 71.0) 62.1 (47.9, 72.9) 56.1 (34.7, 61.2) 56.3 (49.6, 64.3)
Sex
N 145 135 15 40
Female, n (%) 55 (37.9) 56 (41.5) 4 (26.7) 11 (27.5)
Ethnicity
N 145 135 15 40
White, n (%) 67 (46.2) 73 (54.1) 10 (66.7) 19 (47.5)
Black Caribbean, n (%) 26 (17.9) 17 (12.6) 1 (6.7) 3 (7.5)
Black African, n (%) 33 (22.8) 24 (17.8) 1 (6.7) 10 (25.0)
South Asian, n (%) 15 (10.3) 16 (11.9) 2 (13.3) 6 (15.0)
Chinese, n (%) 1 (0.7) 1 (0.7) 0 (0.0) 0 (0.0)
Other,a n (%) 3 (2.1) 4 (3.0) 1 (6.7) 2 (5.0)
Weight (kg)
N 143 135 15 40
Mean (SD) 80.8 (20.5) 79.2 (18.8) 82.5 (13.8) 82.8 (24.8)
Median (Q1, Q3) 77.0 (66.1, 92.2) 76.4 (65.4, 90.8) 83.0 (67.5, 91.5) 78.5 (67.4, 90.7)
BMI (kg/m2)
N 143 135 15 40
Mean (SD) 28.8 (6.5) 28.5 (6.5) 28.8 (5.5) 29.2 (8.8)
Median (Q1, Q3) 28.0 (24.5, 32.0) 27.0 (23.8, 32.2) 27.8 (24.2, 32.4) 27.6 (22.3, 32.6)
Smoking
N 145 135 15 40
Current, n (%) 19 (13.1) 18 (13.3) 0 (0.0) 5 (12.5)
Former, n (%) 45 (31.0) 39 (28.9) 4 (26.7) 10 (25.0)
Never, n (%) 81 (55.9) 78 (57.8) 11 (73.3) 25 (62.5)
SBP (mmHg)
N 142 135 15 40
Mean (SD) 138.6 (23.4) 134.4 (21.3) 133.9 (22.6) 134.1 (17.5)
Median (Q1, Q3) 138.0 (121.8, 153.9) 133.7 (121.3, 147.5) 130.0 (115.0, 152.2) 131.5 (121.0, 142.8)
DBP (mmHg)
N 142 135 15 40
Mean (SD) 73.4 (13.7) 72.6 (15.4) 75.5 (15.4) 76.9 (10.0)
Median (Q1, Q3) 73.3 (63.2, 81.7) 71.3 (61.3, 82.7) 74.0 (67.0, 80.7) 76.8 (70.8, 81.5)
Peripheral vascular disease
N 145 135 15 40
Yes, n (%) 6 (4.1) 5 (3.7) 0 (0.0) 0 (0.0)
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Patients not withdrawn Patients withdrawn
Control Intervention Control Intervention
Diabetes
N 145 135 15 40
Yes, n (%) 59 (40.7) 52 (38.5) 6 (40.0) 15 (37.5)
Hypertension
N 145 135 15 40
Yes, n (%) 116 (80.0) 101 (74.8) 11 (73.3) 33 (82.5)
Hyperlipidaemia
N 145 135 15 40
Yes, n (%) 39 (26.9) 23 (17.0) 4 (26.7) 5 (12.5)
Previous MI
N 145 135 15 40
Yes, n (%) 21 (14.5) 14 (10.4) 0 (0.0) 6 (15.0)
Heart failure
N 145 135 15 40
Yes, n (%) 17 (11.7) 14 (10.4) 0 (0.0) 1 (2.5)
Cerebrovascular events
N 145 135 15 40
Yes, n (%) 17 (11.7) 8 (5.9) 1 (6.7) 0 (0.0)
Cardiovascular
N 145 135 15 40
Yes, n (%) 25 (17.2) 30 (22.2) 2 (13.3) 12 (30.0)
Musculoskeletal and orthopaedic condition
N 145 135 15 40
Yes, n (%) 19 (13.1) 16 (11.9) 1 (6.7) 7 (17.5)
Hb
N 141 127 15 37
Mean (SD) 110.2 (12.1) 109.8 (14.1) 118.1 (14.2) 108.9 (15.8)
Median (Q1, Q3) 109.0 (103.0, 119.0) 110.0 (102.0, 118.5) 115.0 (109.0, 124.0) 110.0 (100.0, 120.0)
CRP (mg/l)
N 139 125 15 36
Mean (SD) 15.3 (21.1) 11.9 (15.9) 12.5 (16.4) 21.1 (26.6)
Median (Q1, Q3) 6.6 (3.1, 18.1) 6.0 (3.0, 14.1) 8.0 (4.5, 11.0) 10.9 (4.3, 28.1)
Dialysis efficiency (%)
N 141 125 15 37
Mean (SD) 71.2 (8.4) 71.9 (7.3) 71.0 (11.3) 71.6 (7.9)
Median (Q1, Q3) 72.0 (66.0, 77.0) 73.0 (69.0, 76.5) 74.0 (68.0, 77.8) 71.8 (66.0, 77.0)
CRP, C-reactive protein; DBP, diastolic blood pressure; Hb, haemoglobin; MI, myocardial infarction; SBP, systolic blood
pressure; URR, urea reduction ratio.
a Indian, Pakistani, Bangladeshi.
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Outcomes
The results for the primary and secondary outcome measures are presented in Tables 3 and 4. The
mean difference in the change in PCS score from baseline to 6 months between the intervention group
and control group was 2.4 AUs (95% CI –0.1 to 4.8 AUs; p = 0.055). In the whole sample, despite no
statistical improvement in PCS score (p = 0.055), it is noteworthy that the absolute mean difference in
change in PCS score from baseline to 6 months between the intervention group and control group was
2.4 AUs (95% CI –0.1 to 4.8 AUs).
TABLE 2 Summary of exercise adherence in the intervention group at 13 weeks and 6 months
Variable
Time point
13 weeks 6 months
Percentage of expected sessions completed
NObs (NMiss) 162 (173) 107 (228)
Mean (SD) 46.7 (31.0) 48.7 (29.5)
Median (IQR) [range]34 46.5 (23.0–71.8) [0.0–100.0]17 47.3 (28.0–77.2) [0.0–97.7]
Dropouts
NObs (NMiss) 160 (175) 119 (216)
No, n (%) 123 (76.9) 92 (77.3)
Yes, n (%) 37 (23.1) 27 (22.7)
Temporary cessation
NObs (NMiss) 160 (175) 119 (216)
No, n (%) 74 (46.2) 50 (42.0)
Yes, n (%) 86 (53.8) 69 (58.0)
Exercise prescription adherence
NObs (NMiss) 160 (175) 119 (216)
No, n (%) 113 (70.6) 98 (82.4)
Yes, n (%) 47 (29.4) 21 (17.6)
NMiss, number of missing numeric values; NObs, number of records/observations in the data set.
TABLE 3 Kidney-specific QoL: primary and secondary outcome measures
Outcome measure Group n
Time point, mean (SD) Adjusted mean difference in
change between exercise
group and control group




Control 120 32.9 (11.3) 31.8 (11.3) 2.37 (–0.06 to 4.80) 0.055




Control 122 39.8 (26.0) 41.4 (24.9) 0.09 (–5.58 to 5.76) 0.97
Intervention 114 40.3 (27.2) 41.4 (26.4)
KDQoL-SF burden
score, AU
Control 122 36.0 (28.6) 37.3 (29.7) –1.42 (–6.95 to 4.11) 0.61
Intervention 113 37.3 (27.7) 36.9 (29.0)
Adjusted mean differences have been calculated in linear regression analyses predicting the outcome from treatment,
adjusting for baseline value of the outcome, age, sex and diabetes at randomisation.
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TABLE 4 Secondary outcome measures
Outcome measure Group n
Time point, mean (SD) or median (IQR)
Adjusted treatment effect (95% CI) p-valueBaseline 6 months
Peak aerobic capacity (VO2max to VO2peak) (l/minute) Control 68 0.97 (0.38) 0.96 (0.37) 0.047 (–0.029 to 0.124) 0.22
Intervention 75 0.95 (0.42) 0.98 (0.43)
Peak aerobic capacity (VO2max to VO2peak) (ml/kg/minute) Control 68 11.9 (4.5) 11.8 (4.2) 0.75 (–0.20 to 1.71) 0.12
Intervention 74 11.8 (5.3) 12.4 (5.7)
Arterial stiffness via PWV (msec) [ln(x+ 1)] Control 78 8.10 (6.78–9.29) 7.78 (6.97–9.13) 1.014 (0.971 to 1.059)a 0.54
Intervention 78 7.92 (6.62–9.09) 7.88 (6.98–9.27)
Duke Activity Status Index (points) Control 121 23.1 (13.1) 22.7 (13.4) 0.35 (–2.23 to 2.93) 0.79
Intervention 112 24.9 (13.3) 24.1 (14.3)
International Physical Activity Questionnaire,
total physical activity (MET-minutes/week) [ln(x+ 10)]
Control 118 423.8 (39.0–1465.4) 353.2 (46.1–1033.1) 1.36 (0.84 to 2.21)a 0.21
Intervention 106 709.5 (153.8–2515.1) 591.0 (111.8–1793.2)
10mTUG [gait speed (m/s) over 10 metres] Control 84 0.86 (0.30) 0.87 (0.29) 0.009 (–0.041 to 0.058) 0.73
Intervention 79 0.94 (0.29) 0.94 (0.30)
STS60 (points) Control 87 13.8 (6.6) 14.4 (7.0) 1.02 (–0.42 to 2.47) 0.16
Intervention 82 15.8 (7.1) 17.1 (8.1)
Tinetti Falls Efficacy Scale [ln(x)] Control 122 22.5 (10.2–46.8) 24.5 (11.0–50.0) 0.943 (0.796 to 1.117)a 0.49
Intervention 112 23.0 (11.8–49.2) 24.5 (11.0–46.2)
EQ-5D-5L health utility score (points) Control 121 0.688 (0.254) 0.675 (0.261) 0.011 (–0.044 to 0.065) 0.69
Intervention 111 0.710 (0.223) 0.697 (0.253)
EQ-5D-5L VAS score (points) Control 121 59.4 (22.7) 59.3 (20.9) 3.52 (–1.02 to 8.05) 0.13
Intervention 111 60.7 (22.2) 63.7 (19.3)
a Exponential of estimate for log-transformed variable.
Adjusted mean differences have been calculated in linear regression analyses predicting the outcome from treatment, adjusting for baseline value of the outcome, age, sex and
diabetes at randomisation. Some variables have been transformed to enhance model fit. Transformations are given in brackets. Treatment effects for variables analysed as





























The number of hospitalisations, all-cause mortality and cardiovascular mortality were not different
between the groups. Although these results should be interpreted cautiously owing to the lack of
events for these secondary outcomes, there was no obvious increase in SAEs in the intervention group
either (Tables 5 and 6).
TABLE 5 Numbers of hospitalisations and mortality
Variable Group n
Number of hospitalisations
(hospitalisation rate per person-year)
Incident rate
ratio (95% CI) p-value
Number of
hospitalisations
Control 160 84 (0.54) 1.45 (0.98 to 2.15) 0.064
Intervention 175 132 (0.85)
Variable Group n




All-cause mortality Control 160 9 (5.76) 1.19 (0.48 to 2.94) 0.71
Intervention 174 10 (6.46)
Cardiovascular
mortality
Control 160 3 (1.92) N/A N/A
Intervention 174 2 (1.29)
N/A, not applicable.
Incident rate ratios have been calculated in negative binomial regression predicting number of hospitalisations from
treatment, adjusting for age, sex and diabetes at baseline. Hazard ratios have been calculated in Cox proportional
hazards regression models predicting survival from treatment, adjusting for age, sex and diabetes at baseline. Models
for cardiovascular survival did not adjust for sex.
TABLE 6 Number of patients with at least one SAE by MeDRA’s System Organ Class, by allocated treatment (all patients,
events occurring on or after randomisation)
Variable All, n (%)
Group, n (%)
Control Intervention
Number of randomised patients 335 160 175
Number of patients with any event 125 56 69
Blood and lymphatic system disorders 2 (0.6) 0 (0.0) 2 (1.1)
Cardiac disorders 15 (4.5) 6 (3.8) 9 (5.1)
Congenital, familial and genetic disorders 1 (0.3) 1 (0.6) 0 (0.0)
Gastrointestinal disorders 14 (4.2) 4 (2.5) 10 (5.7)
General disorders and administration site conditions 17 (5.1) 12 (7.5) 5 (2.9)
Hepatobiliary disorders 3 (0.9) 1 (0.6) 2 (1.1)
Infections and infestations 47 (14.0) 18 (11.2) 29 (16.6)
Injury, poisoning and procedural complications 28 (8.4) 12 (7.5) 16 (9.1)
Investigations 5 (1.5) 4 (2.5) 1 (0.6)
Metabolism and nutrition disorders 17 (5.1) 4 (2.5) 13 (7.4)
Musculoskeletal and connective tissue disorders 4 (1.2) 1 (0.6) 3 (1.7)
Neoplasms benign, malignant and unspecified (including cysts and polyps) 1 (0.3) 0 (0.0) 1 (0.6)
Nervous system disorders 8 (2.4) 3 (1.9) 5 (2.9)
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Subgroup analyses
In patients who completed > 30% of their prescribed exercise sessions, the difference in the change in
PCS score was ≈ 3 AUs and statistically significant (p = 0.039). The relationship between compliance
(as percentage of sessions completed) and PCS score was not significant [estimated change in PCS score
per 10% difference in compliance, 0.6 AUs (95% CI –0.1 to 1.3 AUs); p = 0.11] (Table 7). The relationship
between compliance (as percentage of sessions completed) and VO2peak was weak but statistically
significant [estimated change in VO2peak per 10% difference in compliance, 0.3 ml/kg/minute (95% CI
0.0 to 0.6 ml/kg/minute); p = 0.047] (Table 8).
TABLE 6 Number of patients with at least one SAE by MeDRA’s System Organ Class, by allocated treatment (all patients,
events occurring on or after randomisation) (continued )
Variable All, n (%)
Group, n (%)
Control Intervention
Psychiatric disorders 4 (1.2) 1 (0.6) 3 (1.7)
Renal and urinary disorders 1 (0.3) 1 (0.6) 0 (0.0)
Reproductive system and breast disorders 2 (0.6) 1 (0.6) 1 (0.6)
Respiratory, thoracic and mediastinal disorders 13 (3.9) 3 (1.9) 10 (5.7)
Skin and subcutaneous tissue disorders 1 (0.3) 0 (0.0) 1 (0.6)
Social circumstances 1 (0.3) 1 (0.6) 0 (0.0)
Surgical and medical procedures 37 (11.0) 13 (8.1) 24 (13.7)
Vascular disorders 10 (3.0) 6 (3.8) 4 (2.3)
MeDRA, Medical Dictionary for Regulatory Activities.
TABLE 7 Subgroup analysis of KDQoL-SF PCS score by percentage of expected exercise sessions completed (categorical)
Variable
Expected exercise sessions completed
Control group < 30% ≥ 30% but < 50% ≥ 50% but < 70% ≥ 70%
n 120 25 28 21 29
Baseline, mean (SD) 32.9 (11.3) 32.3 (11.8) 36.0 (11.6) 36.0 (13.0) 32.2 (7.2)
6 months, mean (SD) 31.8 (11.3) 29.1 (10.2) 37.6 (12.2) 37.7 (11.7) 33.7 (11.7)
Change from
baseline to
6 months, mean (SD)






and control group p-value
< 30% completed vs. control completed –2.61 (–6.64 to 1.42) 0.20
≥ 30% but < 50% completed vs. control completed 3.71 (–0.15 to 7.57) 0.059
≥ 50% but < 70% completed vs. control completed 3.67 (–0.67 to 8.01) 0.097
≥ 70% completed vs. control completed 2.88 (–0.98 to 6.73) 0.14
Overalla 0.039
a Overall refers to the test comparing the model with the compliance variable to the model without the
compliance variable.
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TABLE 8 Subgroup analysis of peak aerobic capacity (VO2max to VO2peak) (ml/kg/minute) by percentage of expected
exercise sessions completed (categorical)
Variable Control group





< 70% ≥ 70%
n 68 13 20 17 19
Time point
Baseline



























Change from baseline to 6 months
Mean (SD) –0.2 (3.1) –0.8 (3.5) 0.6 (3.2) 0.3 (2.5) 1.6 (2.6)
Median (IQR)
[range]
–0.0 (–1.7 to 1.6)
[–7.6 to 9.5]
0.0 (–0.9 to 0.9)
[–11.9 to 2.1]
0.5 (–1.2 to 2.7)
[–4.8 to 7.2]
0.7 (–0.8 to 2.3)
[–4.6 to 4.2]
1.6 (–0.2 to 3.0)
[–3.0 to 6.5]
Variable
Adjusted mean difference (95% CI)
in change between intervention
group and control group p-value
< 30% completed vs. control completed –1.01 (–2.73 to 0.71) 0.246
≥ 30% but < 50% completed vs. control completed 1.22 (–0.23 to 2.67) 0.098
≥ 50% but < 70% completed vs. control completed 0.09 (–1.45 to 1.62) 0.911
≥ 70% completed vs. control completed 1.79 (0.31 to 3.27) 0.018
Overalla 0.037
a Overall refers to the test comparing the model with the compliance variable to the model without the
compliance variable.
Summaries for all patients with peak aerobic capacity (VO2max to VO2peak) (ml/kg/minute) at baseline and at the 6-month
follow-up and compliance information available.
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Chapter 4 Health economic evaluation
Background and methods
For the health economic evaluation, we compared the PEDAL intervention as an add-on to dialysis
with dialysis alone. We estimated the mean between-group difference in costs of the intervention and
the mean between-group difference in QALYs accrued by participants during the study, estimated
as the area under the health utility curve. All costs and QALY differences were estimated over the
6-month period from randomisation; discounting future costs and effects for societal time preference
is not relevant. Total costs and 1 –QALYs were modelled using a generalised linear regression model
with a Gaussian distribution and a log-link, adjusting for age, sex and diabetes at baseline. The modified
Park test was used to determine the distribution family for the model.
Intervention costs included costs for purchase and maintenance of exercise equipment (pro-rated to
apply to the 6-month study period), initial training and supervision of staff, staff delivery of the exercise
sessions and the number of sessions. Different scenarios for staff costs have been considered, varying
situation on pay band, including/excluding London allowance and varying staff–patient ratios. The
scenarios have been based on the staffing assumed to be required when implementing the exercise
sessions in usual care, not within the trial. All costs were in Great British pounds; no currency
conversions were required.
The cost of the equipment was assumed to be £1000 and the expected lifetime was assumed to be
10 years.This is the estimated cost of the modifiedMonark cycle ergometer if it were to be commercially
available. Equipment costs over the 6-month study period were therefore assumed to be £50.The maintenance
cost was £50 per year per bike. This is the cost of a call-out fee and any reasonable wear-and-tear
replacements by the manufacturer. It was assumed that one bike covers four patients; therefore,
equipment cost per patient was assumed to be £18.75 [(£50 + £25) ÷ 4] when doing the expected
number of exercise sessions.
The level of staff required was assumed to be Agenda for Change band 4. This would be the level of
staff required in the NHS to deliver this type of exercise intervention. Annual employer costs are
£25,865.7180–30,114.3716 outside London and £30,065.7180–34,786.9716 in London. Cost per hour
is calculated as annual staff cost ÷ 46 work weeks per year ÷ 37.5 work hours per week. The number of
staff required to cover training sessions depends on the distances between satellite units of each study
centre. It was assumed that 0.6 members of staff are required to cover training sessions for 12–20 patients.
Values of 12 and 20 were used in the analysis. The level of staff required to supervise exercise sessions and
train staff to deliver the sessions was assumed to be paid, Agenda for Change band 8. Annual employer
costs are £55,078.005–64,755.960 outside London and £61,741.005–71,418.960 in London. It was
assumed that one member of staff covers 80 patients.
The expected number of sessions over 6 months was calculated as 365.25 ÷ 2 ÷ 7 × 3 (three sessions per week).
The number of sessions completed was calculated as number of expected sessions × percentage
compliance reported in the eCRF ÷ 100. The cost per session was derived as (equipment cost + staff cost
over 6 months) ÷ number of expected sessions for 6 months. The intervention cost per patient was
derived as number of sessions actually attended × cost per session.
Costs in the control group were set to 0, because they received no additional intervention and,
therefore, required no additional staff time or equipment.
DOI: 10.3310/hta25400 Health Technology Assessment 2021 Vol. 25 No. 40
Copyright © 2021 Greenwood et al. This work was produced by Greenwood et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use,
distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/.
For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.
23
The area under EQ-5D-5L health utility curve was derived as follows. Only the period from study entry
(i.e. randomised and baseline visit complete) to 6 months was taken into account. If the baseline visit
was on the date of study entry, the EQ-5D-5L health utility score collected at that visit was used in the
calculation as EQ-5D-5L health utility score at entry. If the baseline visit was before randomisation,
EQ-5D-5L health utility score was derived as follows:
l if there is no follow-up visit, starting EQ-5D-5L health utility score will be the baseline EQ-5D-5L
health utility score
l if there is a follow-up visit, starting EQ-5D-5L health utility score will be determined through linear
interpolation between baseline and the earliest follow-up visit thereafter.
The area under curve was derived as follows:
l If the patient was not dead and had no follow-up beyond baseline, the 6-month EQ-5D-5L health
utility score was assumed to be the same as the EQ-5D-5L health utility score at entry. The area
under the EQ-5D-5L health utility curve was derived as 365.25 ÷ 2 × EQ-5D-5L health utility score
at entry.
l If the patient had their 6-month visit after 6 months from entry, EQ-5D-5L health utility score at
6 months was derived through linear interpolation between EQ-5D-5L health utility score at entry
and EQ-5D-5L health utility score at 6-month visit. The area under the EQ-5D-5L health utility
curve was derived as 365.25 ÷ 2 × (EQ-5D-5L health utility score at entry+ EQ-5D-5L health utility score
at 6 months) ÷ 2.
l If there was no follow-up available and the patient died after 6 months, EQ-5D-5L health utility
score at the time of death was set to 0 and the EQ-5D-5L health utility score at 6 months was
derived through linear interpolation. The area under the curve was derived as in the point above.
l If the 6-month visit occurred before 6 months, the EQ-5D-5L health utility score at 6 months was
derived through linear interpolation between the 6-month visit and the next available information after
that, either EQ-5D-5L health utility score at a following visit or at death, with EQ-5D-5L health utility
score at death assumed to be 0. The area under the curve was then determined as time from entry to
6-month visit × (EQ-5D-5L health utility score at entry + EQ-5D-5L health utility score at 6-month
visit) ÷ 2 + time from 6-month visit to 6 months × (EQ-5D-5L health utility score at 6-month visit +
EQ-5D-5L health utility score at 6 months) ÷ 2. If there was no information after 6-month visit,
EQ-5D-5L health utility score at 6 months was assumed to be the same as EQ-5D-5L health utility
score at 6-month visit.
Estimated between-group differences in cost and QALYs were obtained by the method of recycled
prediction in 5000 bootstrap samples. The distribution of these quantities was summarised and
presented graphically in the incremental cost-effectiveness plane.
To assess whether or not the effect of treatment on QALYs differed between subgroups by age, sex
and diabetes, interaction effects of these variables with treatment were added to the regression model.
Results
Table 9 shows means and CIs for costs from different sources under different scenarios for staff costs.
Estimates shown assume that staff are on average pay for their pay band. Average total costs per
patient over 6 months range from £231.70 (95% CI £204.30 to £259.10) to £423.90 (95% CI £373.70
to £474.10), depending on location and staff–patient ratio. The main cost factor is the staff cost for
delivering the exercise sessions.
The mean of the area under the EQ-5D-5L curve was 0.665 (SD 0.248) in the control group and 0.653
(SD 0.269) in the intervention group. The mean difference between the treatment group and the
intervention group, obtained using the method of recycled predictions, was –0.012, indicating lower
QoL in the intervention group than in the control group, although the 95% CI (–0.069 to 0.043)
included no difference. No significant subgroup effects were found for age, sex or diabetes at baseline.
HEALTH ECONOMIC EVALUATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
24
Figure 2 shows the estimated differences in cost and QALYs on the ICER plane for the low
staff–patient ratio outside London as an example.
TABLE 9 Mean costs per patient for the intervention over 6 months, based on observed number of sessions
Variable


























































Staff salaries are assumed to be at the middle of Agenda for Change band 4 for the staff running the exercise sessions
and at the middle of Agenda for Change band 8 for staff providing training and supervision. Estimated differences in
cost obtained by the method of recycled prediction in 5000 bootstrap samples, setting cost in the control group to 0,

































–0.10 –0.05 0.00 0.05
Effect of intervention – effect of control
FIGURE 2 Cost-effectiveness on ICER plane, 5000 bootstrap samples, low staff–patient ratio and outside London.
Reproduced with permission from Greenwood et al.1 This is an Open Access article distributed in accordance with the
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and
build upon this work, for commercial use, provided the original work is properly cited. See: https://creativecommons.org/
licenses/by/4.0/. The figure includes minor additions and formatting changes to the original figure.
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Discussion
The economics results suggest that, over 6 months of implementation, the PEDAL intervention resulted
in higher NHS costs with no gain in QoL measured with the EQ-5D-5L. A number of factors should be
borne in mind; for example, the benefit from the PEDAL intervention could be avoiding cardiovascular
events and other illnesses in future years, and the 6-month time horizon would not capture this. The
PEDAL protocol could be refined to target different patients on dialysis and/or to include a time point
at which the benefit of the intervention was assessed, with only those reporting a good QoL gain
continuing; both of these could potentially improve the cost-effectiveness.
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Chapter 5 Qualitative substudy
Background
A secondary aim of the PEDAL trial was to explore and document the views of participants and
members of the renal care teams in relation to their experiences of usual care and usual care
augmented with intradialytic exercise. The qualitative substudy used a constructivist phenomenological
approach35 to provide insights into the progress and conduct of the trial in all five study regions. Views
and experiences of service providers and study participants were explored, including control group
participants and those who did not complete the intervention. This report describes the positive and
negative impacts of participating in intradialytic exercise (where a person chose to and was able to
participate). It explains individual and contextual influences on decision-making and experiences as well
as influences of the RCT context.
Qualitative substudy aims and objectives
The aim was to explore participants’ and renal care teams’ expectations and experiences of exercise
training, with the particular aims of understanding:
l the beliefs and attitudes of participants and of the renal care teams towards exercise training as a
treatment and how this might affect QoL
l the acceptability and experience of the intradialytic exercise training intervention as well as how
being in the usual-care group affected behaviour.
Methods
Study design and methodology
The qualitative substudy of the multiregion PEDAL RCT used a constructivist phenomenological
approach.35 This aimed for ‘empathic neutrality’ through researcher reflexivity36 and was led by a
researcher (CB) who was not involved with the rest of the trial. Face-to-face interviews were
conducted using a semistructured topic guide. The substudy was included in the initial RCT ethics
submission, and major amendments were submitted to the relevant NHS Research Ethics Committee
to include relevant documentation.
Participants and study context
Anyone who met the criteria for and participated in the PEDAL trial in the intervention group or usual-
care group, or who had dropped out of the intervention but not the study, was invited to participate as
long as they could communicate sufficiently to be understood in English. To ensure representation of
diverse views, people from each of these ‘categories’ were invited to participate at each site. Potential
interviewees were provided with an invitation letter and response form.
‘Providers’ were also recruited, with the aim of including a range of people involved in providing the study
intervention and whose working roles might be impacted by the trial. Representation was sought from
people in various medical, nursing and support roles in the renal unit and from the PEDAL trial team.
Selected and willing individuals were interviewed once during the life of the study. Trial participants
had consented to the substudy as part of the PEDAL RCT; however, it was considered appropriate to
issue an invitation with more specific information at the point of qualitative recruitment at each site.
It was also important to give renal care providers information. At each site, potential participants were
given the invitation letter by a member of the PEDAL trial team based at that site at least 1 week
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before the day of data collection. The interviewer was introduced to a potential participant by the
same person and started by providing an opportunity for the potential participant to ask any further
questions and accept or decline interview. All PEDAL trial participants who were approached were
happy to be interviewed.
Data collection procedure
Face-to-face interviews involved primarily one researcher and one participant (patient or provider).
On one occasion, two providers wished to be interviewed together for pragmatic reasons, and on one
occasion two patients in a side room wished to be interviewed together. Patients were interviewed
when they came in for HD and providers were interviewed opportunistically to minimise disruption to
their days. The majority of participants were interviewed by the same person (CB), who has expertise
in health-related qualitative research, with a minority of interviews conducted by a supervised research
assistant (who was trained by CB).
Topic guides were designed to focus on the study aims and were informed by review of relevant
literature. Questions of interest were designed and sequenced using guidelines from Kreuger37 to move
from more general to more specific information and to enable an ‘easing’ into the interview process.
Finally, participants are asked for the most important aspect of the discussion in their view. Questions
were reframed as needed to ensure that it was possible to elicit both the required topics or information
as well as unexpected views and experiences, without implying values or demonstrating expectations
in relation to responses. Draft topic guides were reviewed and approved by the PEDAL trial project
team prior to ethics review. The final topic guides are provided on the NIHR project page (URL:
www.journalslibrary.nihr.ac.uk/programmes/hta/122309#; accessed 14 April 2021). Interviews were
audio-recorded. General patient characteristics emerged through interviews, with more specific details
extracted after unblinding of the PEDAL trial. Profession and role were noted for providers.
Data processing and analysis
Data protection guidelines were carefully adhered to for all transportation of data through download
of audio-recordings to an encrypted laptop. Study rigour was enhanced through purposive sampling,
multiple coding of a sample of data, ensuring an audit trail during analysis, and triangulation of data
from different sites and regions, as well as through inclusion of people with a diversity of roles in
relation to the PEDAL trial and intervention.35 Data processing and subsequent framework analysis
aimed at increasing abstraction while reflecting nuances, with development of theory to explain views
and experiences in this study38 (Table 10). Analysis of all data collected in two different regions was
carried out by the lead researcher (CB), who created the initial thematic framework. Subsequently,
a research assistant (Jane Scullion) analysed all remaining data and coded this in NVivo version 10 (QSR
International, Warrington, UK), applying and modifying the thematic framework through regular discussion
with the lead researcher (CB). Mapping and interpretation, with triangulation and development of
overarching theory, were carried out by the lead researcher (CB).
Results
Summary of data and participant characteristics
Interviews took place in all five regions: two sites in London, two in Central Scotland and one in each
of the other regions. Owing to the staggered start to recruitment at different sites, and recruitment
over time within sites, people were interviewed at different points in their trial journey. Interviews
took place over 16 months, between May 2016 and September 2017.
Tables 11 and 12 summarise participant recruitment numbers in each region (patients and providers,
respectively) for the qualitative substudy. According to baseline numbers, 17% of participants in the
trial were interviewed, which increased to 22% when considering numbers at the 6-month follow-up.
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TABLE 10 Data processing and analysis
Stage Description
Intelligent verbatim transcription Professional transcription without false starts and vocalised hesitations
(e.g. ‘emm’); use of pseudonyms and removal or appropriate modification of
any identifiable information
Transcript modification Appropriate additions from researcher’s reflexive field notes
Upload to NVivoa Processed transcripts were uploaded to NVivoa for data and analysis
management
Familiarisation with the text Reading and re-reading of transcripts; annotation of key ideas with
summary labels
Theme development Synthesis of labels to link similar ideas, views or concepts and define these as
subthemes, subsequently grouped into themes
Thematic framework development Organisation of themes into a logical framework, with allocation of codes to
enable organisation of information using NVivo v10 software
Application of thematic framework Re-reading and analysis of each transcript using the new thematic framework,
with incorporation of any new themes
Coding in NVivoa Coding of themes emerging in text using NVivoa to ensure an audit trail
Mapping and interpretation Descriptive relationships between themes were sought, for example where
a participant connected two ideas with ‘. . . happened because . . .’, enabling
development of a map of interconnected ideas and explanatory theory for
the findings
Triangulation Analysing patterns and differences between results for different geographical
regions and renal units, providers and participants
Development of overarching theory Theory generation, with the aim of explaining the data in the study
a NVivo version 10 (QSR International, Warrington, UK).
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When looking at the 6-month follow-up time point, 16% of all intervention participants who completed
participation, 13% of control group participants and 40% of those who did not or could not continue
participating in the intervention were interviewed.
Trial participants included in the qualitative substudy included 26 women (46%) and 31 men (54%).
There was substantial diversity in terms of age, months since starting dialysis and ethnicity. There was
a mean age of 60 years, with a mean HD vintage of 43 months (data unavailable for 14 participants).
Most people were receiving HD for 4 hours (range 3.5–5.0 hours) three times per week. Ethnic
diversity among participants was greatest in London, the West Midlands, and North Wales and North
West; it was lowest in Central Scotland and at the site of interviewing in the East Midlands. Where
ethnicity was noted, there was representation from Asian British (Pakistani and Indian), black
Caribbean and white British people.
People were interviewed at different points in their trial journey, at a mean of 11 months from
consenting to participate in the trial and 8 months from their baseline assessment.
Explanatory theory and supporting thematic analysis
Analysis of the substantial quantity of data resulted in an explanatory model, depicted in Figure 3.
This will be both explained and justified, supported by illustrative data. Explanation will move from the
centre of the figure outwards, focusing first on the outcomes when people sustained participation in
the intervention over time. The individual influences on decision-making about participation over time
will then be explored, followed by contextual influences. Finally, an explanation of how the RCT
context of participation affected decision-making will be addressed. Table 13 provides theme names
and definitions.
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FIGURE 3 Explanatory theory relating to individual-decision-making about starting and continuing participation in
exercise while on HD.
TABLE 13 Summary of themes and definitions
Theme/subtheme Definition
Reciprocal influences between impacts of participation and ongoing participation in cycling while receiving HD
Impacts of participation
Positive physical impacts Positive physical impacts of intervention participation,
including more energy, increased time on bike, increased
strength, reduced weight, increased walking time, improved
appetite, improved circulation, feeling fitter, improved
stamina, reduced sickness, less breathlessness and help
with restless leg syndrome
Positive functional impacts Positive functional impacts of intervention participation,
including increased mobility, improved sleep pattern and
improved balance
Positive psychological impacts Positive psychological impacts of intervention participation,
including hope, feeling happier, increased self-esteem,
passing the time and distraction from negative thoughts,
enjoyment of routine, feeling normal again, increased
confidence, feelings of improving health, sense of pride and
becoming more independent
continued
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TABLE 13 Summary of themes and definitions (continued )
Theme/subtheme Definition
Positive impacts on participation in life Positive impacts of the intervention on participation in life,
including increased physical activity, increased social
participation, increased interaction and competition with
others, and perception of a safe space to exercise
Positive impacts on physical activity when outside the
renal unit
Incorporating home exercise and other activity into daily
routines attributed to intervention participation, including
greater walking distance, cycling, getting out and about,
sports participation, feeling more energy and stamina,
and being able to take on more roles in the family
Enjoyment of intervention participation Enjoying the experience of participation in the intervention
Negative experiences of intervention participation Barriers to participation, including negative experiences
of the intervention, such as exacerbation of fatigue and
depression, reduced blood pressure, feeling that exercise
is a ‘shock to the system’, lack of consistency in accessing
the bike, feeling a lack of progression in fitness, lack of
interaction with others while on the bike, musculoskeletal
pain, and uncomfortable/unsafe bike
Individual influences on decision-making: physical activity culture, ability to cycle and social environment
Physical activity culture: personal views and goals and social support relating to physical activity and health status
Positive influence on continuing to cycle
Personal drive for physical activity and exercise Motivators for ongoing participation, including a drive to
participate in physical activity or exercise because of
previous and/or current participation, interest in improving
health, and self-discipline relating to participation (note
that this was influenced by feeling that participation is
making a difference and seeing improvements in the health
of other participants)
Family support Person having family support for involvement in the
intervention, positive attitudes towards exercise, and
feedback about positive perceptions of intervention
impacts
Ability to cycle: physical ability to cycle, renal condition and comorbidities
Barriers to continuing to cycle
Renal condition: ‘bad days’ ‘Bad days’, during which symptoms of the person’s renal
condition feel worse and the person requires more sleep,
rest and support from others
Comorbidities Having comorbidities
Became unwell A change in health status, for example involving blood
pressure, fluid overload or musculoskeletal pain
Social environment: impacts of relationships in the renal unit
Positive impacts on continuing to cycle
Motivational role of staff Motivational influences of staff affected by their attitudes
to exercise, the trial and skills
Camaraderie in the unit relating to cycling Camaraderie, competition and encouragement between
people within the renal unit, including patients and staff
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TABLE 13 Summary of themes and definitions (continued )
Theme/subtheme Definition
Contextual influences on decision-making: social environment, physical activity culture and ability to cycle
Social environment: supportive, proactive culture in the renal unit
Positive impacts on continuing to cycle: supportive social
environment
Relationships with staff and patients in the renal unit that
demonstrate a supportive culture
Attitudes towards empowering and enabling renal
patients
Contrasting attitudes, approaches and barriers to
empowering and enabling renal patients in relation to
self-care
Renal unit proactive about change A renal unit having a culture of being proactive about
change
Physical activity culture in the renal unit: different degrees of expectation, value and empowerment of physical activity
participation
Staff enthusiasm about physical activity and exercise
for patients
A positive attitude to physical activity/the intervention
for renal patients owing to justification/rationale, prior
experiences, beliefs that it is necessary for management of
renal disease, personal beliefs about physical activity/the
intervention, and noticing positive impacts for people
Expectations of renal unit staff about engagement of
patients with exercise
Beliefs that people who are exercising will lose interest or
prefer sedentary activities
Ability to cycle: provision of cycling equipment and support for ongoing access
Barriers to ongoing participation: Lack of opportunities
to cycle
Structural barriers meaning that the exercise bike has not
been available at a suitable time
Themes relating to the trial context
Motives to consent: reasons that people give for their decision to consent to the trial
Giving back (positive for continuing trial participation
unless allocated to intervention group)
Decisions to consent were influenced by the desire to ‘give
back’ – improving knowledge and helping others, including
the next generation
Social influences (positive for continuing unless allocated
to intervention group)
Decisions to consent were influenced by the community in
the dialysis unit and trust in the people promoting the
study and family
Invested in physical activity and exercise (positive for
continuing trial participation unless allocated to
control group)
Decisions to consent were influenced by having been
active (cycling and other) in the past and being currently
invested in achieving health-related benefits, including
those relating to renal condition (e.g. preparation for life-
saving transplant, losing weight, reducing breathlessness)
and broader needs such as increasing mobility, circulation
and playing a more active role in treatment
To pass the time Decisions to consent were influenced by a desire to find a
different/more useful way to pass the time, or as a distraction
Affordable exercise (positive for trial participation unless
in control group)
Decisions to consent were influenced by the fact that it
presented an opportunity to exercise with no cost
Barriers to consent: explanations of negative influences on decisions to consent to trial participation
Conflicting priorities Negative influences from conflicting priorities on a decision
to consent, including a desire to protect ‘good days’ away
from the renal unit and concerns about whether or not
cycling would negatively affect HD
Disinterest in exercise Negative influences from disinterest in exercise on a
decision to consent, including disinterest that may have
been influenced by a lack of education about exercise or a
belief that exercise is not an important part of life
continued
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Impacts of pedalling while on dialysis
The final explanatory model (see Figure 3) provides the key outcomes in the centre; these were the
aim of the intervention and were described very well by multiple participants who were able to sustain
participation in both the trial and the intervention. Impacts included positive physical effects, such as
more energy; increased fitness, stamina and strength; weight reduction; improved circulation; and
reduced shortness of breath, symptoms from dialysis and restless leg:
Well, a bit more energy about me, certainly, than what I had a year ago. I’m getting less of the . . .
problems you might get after you dialyse. When I was doing it [dialysis] first I was still getting . . . quite
sick . . . but as this has gone on it’s improved. And I’m sure that the exercise must be part of that, you
know, it must be helping.
Central Scotland, intervention participant 1
This resulted in functional improvements for some, such as increased mobility and balance and better
sleep patterns. This was described both by people who completed the intervention and by people who
did not or could not continue for the whole period for different reasons such as comorbidities:
Noticing the change in me . . . walking, going up the stairs, coming down the stairs. It’d become so difficult
for me. But after exercise it became easier and easier.
North Wales and North West, participant who did not continue intervention 3
TABLE 13 Summary of themes and definitions (continued )
Theme/subtheme Definition
Not fit to exercise Negative influences from fitness to exercise on a decision
to consent (or ability to be included), including being too
overloaded with fluids, having comorbidities, reduced
strength or reduced mobility
Psychological barriers Negative influences from psychological barriers on a
decision to exercise, including patient perception that their
condition means that they cannot exercise
Experiences of the control group: descriptions of experiences and views relating to being allocated to the control group in the trial
Little change to activities Having made no obvious changes to physical activity levels
during the trial
Willing to help Positive descriptions of willingness/pleasure in being able
to contribute because of perceptions of the trial’s value/
importance, and ability to continue with prior routine
physical activity
Barriers to continuing trial participation: descriptions of barriers to ongoing trial participation
Disappointment about being in the control group Disappointment and sadness about being allocated to the
control group, including because the participant was
invested in increasing their physical activity, exercise
and/or mobility
End of exercise period Frustration at having to stop cycling at the end of the
specified intervention period
Renal unit engagement with the trial: descriptions of influences on the renal unit’s engagement with the PEDAL trial
Negative views about the PEDAL trial/barriers to
engagement described by renal unit staff
Feeling too busy or short staffed to deliver the
intervention, or the intervention not being a priority
owing to conflicting priorities, or there being a lack of
physical space
Positive views about the PEDAL trial/facilitators of
engagement described by renal unit staff
Interest in the study question and intervention and in
research more generally, and hope for better patient
outcomes
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A variety of positive psychological impacts were described, including feeling happier and more hopeful,
having feelings of pride and having increased confidence and self-esteem. Participants felt that time
passed faster, less time was spent with negative thoughts and they enjoyed the routine, and they felt
more ‘normal’ and independent again. One participant explained:
It’s been a really, really good journey. Should I say, I’ve had many ups and downs in that study. But, I
mean, now I’m feeling myself, so I’m much more confident and much quicker . . . because I know if I can
go on to the bike for so long and on a certain resistance . . . I’m getting a bit stronger. So that has
basically boosted my confidence.
North Wales and North West, intervention participant 3
Participants and providers described increased participation in physical activity when outside the renal
unit and greater participation in life more generally, which they attributed to intervention participation:
We’ve got a treadmill at home, hardly used it. And now I’m on it, ‘cause I asked [a PEDAL Trial employee]
what’s the best way to . . . so he did explain and that’s helping me a lot as well.
North Wales and North West, intervention participant 1
It was also evident that there was a feedback loop between the experience of these positive impacts,
enjoyment of the experience overall and the motivation to continue participating in exercise during dialysis.
Some people who did not continue the intervention felt this and were disappointed to have to stop:
Yes, I felt it was doing me good. I was actually enjoying it.
Central Scotland, participant who did not continue intervention 1
Impacts of cycling were not all positive, with some describing feeling uncomfortable or unsafe on
the bike, that there was a lack of interaction with others and that exercise exacerbated fatigue and
depression and other co-existing conditions such as low blood pressure and musculoskeletal pain.
For some people this was a barrier to continuing intervention participation, whereas others completed
the intervention.
People in the control group did not describe these positive or negative feelings or experiences purely
from taking part in the trial. Some had participated to give back and experienced related satisfaction
but did not discuss the kinds of physical, functional, psychological and social impacts of participating in
the trial that were discussed by those experiencing the intervention.
Individual influences on decision-making: physical activity culture, ability to cycle and
social environment
In the explanatory theory (see Figure 1) there is an individual layer of influence on decision-making
and a further contextual layer in the overall background of the RCT scenario. In the individual and
contextual layers there are interacting aspects of the beliefs and culture relating to physical activity,
ability to cycle and social influences.
The patient’s physical activity culture – or personal views, goals and social support relating to physical
activity and their health status – affected their decisions to continue cycling. Motivators included a
drive to participate in physical activity or exercise due to previous and/or current participation and
interest in improving personal health outcomes or goals:
Well, I used to do a lot, I used to go to the gym quite frequently, but because I’ve got polycystic kidneys
and pressure on my lungs it makes it harder for me to do . . . I try to find alternative ways to exercise,
so cycling and walking’s helping quite a bit.
East Midlands, intervention participant 4
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Ability to cycle mattered as well, and most frequently manifested as a barrier to participation (i.e. as a
lack of ability to cycle). The highly variable nature of renal symptoms, influenced by dialysis days,
affected whether or not people were having ‘good days’ or ‘bad days’. This was more likely to affect
the degree of exercise participation over time during dialysis sessions. By contrast, comorbidities and
changes in renal health status, such as fluid overload, blood pressure changes and musculoskeletal pain,
were more likely to affect a person’s ability to continue the intervention:
When it got to the time to do it I discovered I had the problems with my hips, which is why I couldn’t do
the cycling.
East Midlands, participant who did not continue intervention 3
Relationships with other patients, renal unit staff and PEDAL trial staff also affected decisions to
continue cycling. The motivational role of the person directly supporting cycling was very important on
a day-to-day basis:
I talk to them about the benefits of cycling and I remind them of how they felt last time, because I find
generally patients after they’ve cycled do feel good and they enjoyed it and they’re feeling happier with
themselves – and then it’s kind of negotiating . . . I do try to be as encouraging as I can but not pushy . . .
showing a bit of empathy.
London, provider 1
Camaraderie, competition and encouragement between patients in the renal unit influenced some
people, more often where there were multiple people situated together in a bay or in a longer ‘ward’
layout. This was described as a gap where people were in side-rooms:
They make jokes about it and we’ll say, ‘oh, are you on your bike today?’ You know, ‘where have you
been today?’ and things like that . . . The rest of the group were quite encouraging . . . people were
encouraging her.
Central Scotland, provider 4
This camaraderie linked strongly with the contextual layer of the theory: a supportive, proactive
culture in the renal unit.
Contextual influences on decision-making: social environment, physical activity culture and
ability to cycle
A supportive social environment in the renal unit was described at some sites, with positive
relationships within the unit and culture of empowerment:
We’ve done lots of things down here that we’ve tried to motivate the patients with. I mean, we’ve done
art in hospital, we’ve done lots of things, staff here are quite motivated.
Central Scotland, provider 2
A patient explained how important relationships are in the renal unit:
We sort of all really get to know each other, don’t we? And the staff are really supportive, really good.
You’re trusting people with your life, because your fistula’s your life, isn’t it?
West Midlands, control participant 1
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Another provider explained that, from her experience, she thought renal unit staff could empower
or disempower patients unintentionally, through beliefs about ensuring safety, efficiency and
patients’ capabilities:
Of course you can come in and do it yourself, and the biggest resistance I had was not the patients but
the nurses and a lot of it came from . . . that maternal or paternalistic attitude of ‘I’ll do it and I know it’s
done well, or it’s done properly, or I can get done quicker’ . . . you know, you just want to do it right for
them, so I do think that creates an awful lot of it, because they’re with us for a long time, and if we don’t
instil that confidence in them that you can do it, then the patients aren’t going to believe that they can
do as well.
North Wales and North West, provider 1
Some renal units described having a proactive attitude to change:
We like embracing new things on the unit . . . It’s new at first but you adjust to it, no trouble – we seem
to do that here.
North Wales and North West, provider 5
The social culture of the renal unit also linked with attitudes towards physical activity participation and
engagement with the intervention. Staff enthusiasm about physical activity and exercise as necessary
for renal patients was important and related to their awareness of the rationale for it, prior experiences
of exercise for renal patients, personal beliefs about physical activity and exercise as beneficial for all,
and noticing positive changes in participants during the trial. One provider explained:
I would love to see a lot more exercise on the unit. I want to see my patients feel better and have better
outcomes. I certainly see it as one of those things that could be good for that.
East Midlands, provider 9
Some providers described having initial scepticism about whether or not renal patients would engage
with the intervention:
Prior to starting I’d say that I had . . . if anything, sceptical as to what the impact would be . . . They’re not
the most active bunch, renal patients.
East Midlands, provider 5
This may also have interacted with participants’ ability to cycle, owing to structural barriers affecting
whether or not the exercise bike was available at a suitable time:
Sometimes it does get forgotten, and part of that is being busy as well, and short staffed.
Central Scotland, provider 3
One participant explained:
Well, everybody just encouraged me . . . patients and staff. Oh aye. Most of the staff managed to put me
on. But there was a few just didn’t know how to and they kept saying I need to learn how to do this.
Central Scotland, intervention participant 2
Influences of the randomised controlled trial context on decision-making
It is important to remember that the context of participating in a RCT underlies the decision-making
about both starting and continuing to participate in the intervention group and control group.
It was reassuring from a trial perspective that the evidence suggested that participants in the
control group did not increase or decrease their physical activity or exercise during the trial period.
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However, allocation to either the control group or the intervention group had an impact on people
in other ways that affected their willingness to continue participating. People gave different reasons
for consenting to participate in the trial. Some people wished to ‘give back’ because they felt that they
had received so much from the health system and wished to improve knowledge and help people
receiving dialysis in the future. Others wished to participate to pass the time, as they found being in
the renal unit boring. Both of these motivators were valuable if a person was allocated to the control
group, because they might be less invested than someone in the intervention group of the study. For
example, as one control group participant explained:
It’s good to be doing something rather than just sitting here doing nothing. The daytime telly’s not very
good, you know.
East Midlands, control participant 2
If allocated to the intervention group, however, a person may have had less motivation to exercise than
others in the intervention group. Some people consented to the trial because of social influences, for
example seeing others in the unit benefitting from participation. This again was positive if the person
was allocated to the intervention, but less so if allocated to the control group:
So one or two of my co-patients, they volunteered, and they went ahead. So I said, why should I be
left out?
East Midlands, intervention participant 3
A strong motivation to consent involved interest in physical activity and exercise due to having been
active in the past, and currently being invested in achieving health-related benefits, including those
relating to renal condition and broader health and mobility needs. Some people wished to lose weight
specifically to increase their likelihood of transplant. These were emotionally loaded reasons for
participation and meant that a person was very affected by their randomisation:
It’s unfortunate the randomisation of the exercise to control or exercise, and it disappoints, that’s another
thing that we have to take into consideration is somebody’s just been turned down and you’re exercising
somebody in the next bed to them. How do you keep them interested in the trial for 9 months now?
North Wales and North West, provider 4
A participant reinforced this:
. . . if I’m honest I’ve been a bit disappointed because I wasn’t selected to do the cycling and a lot of
people who were selected don’t seem to want to do it. I’m one person who actually did and I was keen to
do it, but I just wasn’t picked, so I’ve been really disappointed about that.
London, control participant 2
In addition, it is important to remember that the trial context formed a barrier for some people who
were interested in exercising but did not wish to attend assessments, particularly on non-dialysis days.
This was complex in relation to conflicting priorities, because people valued their ‘good days’ when not
in the renal unit and were sometimes living at a substantial distance from the location for trial assessments:
The difficulty with the unit here is that we have a fair number of patients who have extended travel times
to get here because they don’t live on the mainland and they have to catch the ferry. And what the study
protocol dictates is that they have to come on a non-dialysis day to have their assessment. And during
the study it was particularly challenging trying to explain this to the patients. Particularly those who were,
you know, there were a fair number who were unhappy about having to attend for assessment if they
didn’t get the intervention.
Central Scotland, provider 4
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One provider stated:
A lot of patients are asking can they not be on the study and still use the bikes, so it’s like a gym on
dialysis . . . There are a few that have said they don’t want to be on the study, but can they use the bike?
East Midlands, provider 6
Another issue relating to the trial context is that in all but one site the intervention was supported by
a dedicated PEDAL trial employee. In the site at which the renal unit supported intervention provision,
a provider described difficulties in prioritising intervention provision at busier times. This could affect
the ability of the person to cycle, owing to access. It is important to note, however, that multiple
providers at other sites explained that, although often enthusiastic about the intervention, they would
not be able to provide it without dedicated staff after completion of the trial:
My ideal scenario would be to have a physio[therapist] that would come in and work with patients, not
just doing PEDAL but doing maybe other stretches and things for renal, that would benefit renal patients
while they’re on dialysis and that would take the nurses out of it.
Central Scotland, provider 3
Another provider stated:
We have got quite a lot of work coming in . . . and sometimes there’s a staff shortage and . . . I don’t think
we’ll be able to support them . . . and if there is nobody to initiate that programme then I don’t think it’s
going to go very far.
North Wales and North West, provider 6
Interlinkages between influences and impacts: explanatory theory
Data clearly support positive impacts from cycling during HD where a person is fit to do so and able
to continue, and these impacts motivated people to continue participation. The trial context affected
whether or not some people decided to take part because, although interested in exercise, they did
not wish to attend assessments on non-dialysis days. The trial context also influenced whether or not
people continued participation in either the control group or intervention group depending on their
reason for consenting to participate.
Where people participated in exercise, their willingness and ability to continue was affected by their
own individual capability to do so, their attitudes, beliefs and family support and their relationships
with those around them in the renal unit. The motivational roles of other patients and PEDAL trial and
renal unit staff cannot be underestimated, and availability of this support was influenced by the culture
and beliefs in the unit. A positive culture of involvement and empowerment was important. This was
particularly well harnessed by one PEDAL trial employee who was able to enlist the support of all
staff in the unit, including medical, nursing and support staff. The impact of this was a unit where all
were encouraging those cycling, resulting in a sense of enthusiasm and camaraderie. This person was
also highly strategic in motivating others to consent to the trial, for example by building relationships
with patients and asking the person who volunteered first to move bays and influence others into
participating through role modelling.
Discussion
Results of the qualitative substudy are largely consistent, with the few existing qualitative studies
exploring health-care provider and patient experiences of intradialytic exercise. The current study
findings go further in relation to theory generation; therefore, it is possible to make some more
in-depth suggestions for further development. The literature search conducted early in the trial was
DOI: 10.3310/hta25400 Health Technology Assessment 2021 Vol. 25 No. 40
Copyright © 2021 Greenwood et al. This work was produced by Greenwood et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use,
distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/.
For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.
39
repeated in June 2020 [searching PubMed, MEDLINE, Cumulative Index to Nursing and Allied Health
Literature (CINAHL), PsycInfo® (American Psychological Association, Washington, DC, USA) and
SPORTDiscus (EBSCO) using the search terms ‘exercise’ and ‘haemodialysis’ and ‘qualitative’, with no
limiters] and no further studies were found.
Young et al.39 conducted a study in the UK of patient and staff perceptions of intradialytic exercise.
They carried out focus groups with 24 patients and 9 staff before implementation and semistructured
interviews with 11 exercising patients and 8 staff members 6 months later. Thompson et al.40 interviewed
25 patients and 11 staff in Canada to explore perceptions of intradialytic exercise. Heiwe and Tollin41
conducted individual interviews in Sweden with six men and four women who were experiencing
implementation of intradialytic cycling. There was a focus in the studies of Young et al.39 and Heiwe and
Tollin41 on identifying barriers and motivators in the data; both looked at the stage of deciding whether or
not to take part, and the former also looked at experiences 6 months later.
There were multiple common themes between the PEDAL trial themes and those in previous studies.
In particular, Young et al.39 found similar functional, psychological and physiological benefits, and
viewed these as providing positive feedback that enhanced ongoing participation. Thompson et al.40
found social benefits but did not focus on analysis of the impacts of exercise. Heiwe and Tollin41
conducted their interviews in the early stages of implementation and found that participants were
motivated partly by a desire to pass the time and felt that this was a good opportunity for exercise.
In addition, they noted that the positive experiences of well-being benefits fed into ongoing
participation, which was evident in our study.
There were common barriers that revolved around staffing and workload, limited resources and
concerns over roles and appropriate training or expertise.39,40 Interestingly, these three studies
delivered the intervention with existing staffing: kinesiologist and nursing staff,40 nursing staff41 and
physiotherapist staff.41 By contrast, in all but one of the renal units represented in the current study,
a dedicated PEDAL trial employee delivered the intervention. The renal unit in the PEDAL trial that
provided its own support for the intervention shared the workload of study implementation between
staff and discussed similar barriers to the previously published studies. Staff in the other renal units
commented on the necessity of dedicated staff time. This may relate also to a theme that was common
to all studies: the importance of motivation, encouragement, reinforcement, feedback and support from
staff to facilitate ongoing participation.
In the context of qualitative data collection and analysis, evidence of support from similar, previous
studies provides further evidence of credibility and trustworthiness of the results, so the similarities in
themes from different countries and contexts are encouraging. Our study was, to our knowledge, the
largest of its kind by far, and had quite diverse participants, which provides valuable triangulation.
The results of this qualitative substudy clearly support the value of exercising while on dialysis for
those who can. We also have useful insights about how to enable people to continue participation over
time, both from feed forward of the positive impacts and through complex social and cultural dynamics
in the renal unit. It is important to consider the insights of analysis for ongoing implementation of the
intervention. The results suggest that a renal unit is an integrated system, with complex interdependencies
and mutual influences on expectations, beliefs and attitudes. Staff and patients are intertwined as a
community and, when considering changing complex behaviours, it is important to remember this. It would
be useful to analyse the findings of this study in relation to current behaviour change theory as a secondary
analysis, for example using the capability, opportunity, motivation, behaviour (COM-B) behaviour change
model, which emerged from the behaviour change wheel of Mitchie et al.42 Interestingly, Young et al.39
considered the importance of influencing behaviours of staff as well as of patients; they recommended staff
training and patient education to increase engagement.We suggest that the need for change goes beyond
knowledge to culture; renal units with proactive and relationship-focused cultures appeared to engage
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people in the intervention in different ways, which may be more sustainable in the long term. In the future
it would be valuable to explore ideas around ways in which providers empower and enable, how this is
influenced by leadership and context and how this affects changes in the behaviours of people engaging in
and sustaining interventions such as exercising while on dialysis.
Conclusions
The explanatory theory developed through the qualitative substudy of the PEDAL trial has provided
in-depth insights into the influences on people’s decision-making relating to participation in both the
trial and the intervention over time. Themes are supported by the few previous qualitative studies;
however, our data are more extensive, and the resulting theoretical explanation goes further to enable
suggestions for future implementation and intervention sustainability. A novel finding relates to the
importance of culture, and leadership to enable this, in the renal unit. Providers interviewed felt that
the trial did not impinge much on their jobs, which supported trial implementation; however, this may
not be conducive to sustainability of the intervention beyond the trial. Moving forward beyond the
PEDAL trial, it will be most important to influence the attitudes, beliefs and behaviours of providers.
Where providers are engaged and empowered, they are much more likely to engage and empower
patients in participating. Once a patient is participating (where capable), the numerous physical,
functional, psychological and social benefits are likely to support their ongoing participation. This in
itself may then feed forward into a positive, proactive culture in the renal unit. Further research is
needed to explore the complexities of intervention implementation in the longer term, with a view to
aspects of behaviour change and insights from implementation science.
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Chapter 6 Discussion and conclusions
Summary of main findings
The aim of the PEDAL trial was to assess clinical effectiveness and cost-effectiveness of a 6-month
intradialytic exercise programme on QoL, compared with usual care for HD in the UK. The PEDAL trial
is novel in that it is the first, to our knowledge, to evaluate intradialytic exercise as would most likely
be delivered nationally, should NHS commissioning include exercise training as part of the service
specification for in-centre HD. Exercise training was delivered by physiotherapy assistants (band 4
technical instructors), supported by regional co-ordinators who were physiotherapists or exercise
physiologists. Thus, the PEDAL trial evaluated the most realistic yet safe exercise rehabilitation
intervention possible in this population.
The baseline demographic data of the PEDAL trial cohort broadly aligns with the ‘real-world’ dialysis
population in the UK as detailed in the latest data from the UK Renal Registry43 and also the PIVOTAL
(Proactive IV iron Therapy in haemodiALysis patients) trial, a recent, large interventional study
conducted in UK renal units.44 Baseline age, sex, BMI, blood pressure, diabetes prevalence and the
proportion of current smokers are all similar to UK Renal Registry data.43 However, the current study
included a larger proportion of black African and black Caribbean participants, and a lower proportion
of white participants, than is representative of the broader prevalent dialysis population in the UK. The
baseline data are similar to most dialysis populations worldwide.45–48 There are some differences in
rates of diabetes prevalence, with lower rates in our patient cohort than in dialysis populations in the
USA and Asia, which may limit application of the results to all other dialysis populations.
As delivered, the PEDAL programme did not improve the QoL of the whole sample, as assessed by
the KDQoL-SF PCS (p = 0.055), nor did it improve QoL as assessed by the secondary outcomes of the
EuroQol-5 Dimensions, five-level version (EQ-5D-5L) or KDQoL-SF multi-item scales. In the whole
sample there were no statistical or absolute changes in functional capacity, physiological variables,
anthropometric measures or clinical measures. More than half (58%) of patients temporarily halted
receiving their exercise intervention for a continuous period of > 2 weeks during the study; in total,
patients completed less than half [47%, interquartile range 28–77%] of exercise sessions that were
prescribed. These data suggest that the HD patients had poor compliance with the exercise
intervention. The nested qualitative study revealed that patient views relating to change in health
status, having comorbidities and having days where there was an increase in symptoms such as
tiredness were possible reasons for not engaging with the exercise intervention. Because predominant
themes were the ‘exercise culture’ and camaraderie that results from exercising with others, a cluster
randomisation design may perhaps have fostered this camaraderie on a whole renal unit level,
preventing the perception of participants feeling ‘left out’ if they were allocated to the control group.
We chose the KDQoL-SF instrument because of its validity in CKD patients49 and inclusion of a generic
core that has been widely used in CKD and other populations. The lack of effectiveness of the PEDAL
programme in the whole sample on PCS score warrants comparison with previous studies. A Cochrane
review9 completed in 2011 concluded that exercise was beneficial for QoL in CKD patients but,
unfortunately, no meta-analysis or risk-of-bias assessment was performed on this outcome measure.
Furthermore, many of the included studies were not representative of the HD population because they
investigated transplant,50 pre dialysis51 or ambulatory peritoneal dialysis52 patients. More recent meta-
analyses have concluded positive effects of exercise but have shown significant effects on the role
physical subscale only,53 showing no effect on PCS score,18 or did not analyse this outcome owing to
insufficient studies.13,54 Other meta-analyses have included non-randomised studies53 or rated studies as
at high risk of bias and showing considerable heterogeneity.14,17,19,54 Previous meta-analyses have also
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included extradialytic exercise programmes19,54,55 or studies that have delivered progressive resistance
training as opposed to aerobic cycling alone.10,15,16,19,20,56 In this regard, one meta-analysis22 usefully
compared aerobic exercise, progressive resistance training and combined exercise; only progressive
resistance training increased PCS score. Detailed analysis of the very few empirical studies included in
reviews that do show positive effects of aerobic intradialytic exercise on QoL reveals that they have
often utilised unrealistic interventions that would be difficult to implement in routine care. For example,
Ouzouni et al.57 investigated an exercise programme similar to the PEDAL programme [intradialytic
cycling plus TheraBands (TheraBand, Akron, OH, USA) and ankle weights] but three physiologists were
employed to intensely supervise only 10 patients for 10 months to obtain a significant effect. Taken
together with the results reported herein, it is highly unlikely that clinically implementable intradialytic
aerobic exercise training per se increases QoL, particularly at a whole-population level.
Nevertheless, there was some evidence of benefits to KDQoL-SF-assessed QoL and aerobic capacity in
patients who completed > 30% of prescribed exercise sessions. Participants, clinicians and researchers
continue to advocate intradialytic aerobic exercise. The PEDAL trial uniquely assessed the cost of
delivery of its intervention using careful recording of harms and using health economic methods. The
number of hospitalisations, all-cause mortality and cardiovascular mortality were not different between
the groups. Although these results should be interpreted cautiously because of the lack of events for
these secondary outcomes, there was no obvious increase in SAEs in the intervention group. The
economic cost of delivering the PEDAL intervention ranged from £882 to £1866 per patient per year
(depending on pay band of the physiotherapy assistant, whether or not London weighting was applied
and staff–patient ratio). This calculation assumed that intradialytic exercise would be offered as part of
a general physiotherapy service (with enough capacity to provide absence cover), with costs profiled
throughout the programme (e.g. exercise equipment cost is shared throughout its service life), with
patients who are 100% compliant and with physiotherapy assistants supervising between 6 and 10
patients per dialysis session without incurring any travel costs. For context, the cost of delivery of HD
in the UK is approximately £35,023.58 Because the PEDAL trial was not clinically effective at a whole-
sample level, whether or not the cost of delivery of intradialytic exercise is justified to enhance patient
choice remains a matter for debate. Because the observed benefits to KDQoL-SF-assessed QoL may be
due to an experimenter effect, a similar improvement in QoL to that achieved herein could arguably
be achieved with less cost and less effort through one-to-one patient interactions and provision of
patient education resources on physical activity.
The PEDAL trial aimed to address a criticism of previous exercise studies that recruited only patients
with high physical health status by having more inclusive inclusion criteria. Perhaps including patients
with lower physical health status prevented benefits of the exercise intervention being realised.
However, this explanation is unlikely because our sample is like other pragmatic exercise studies in
CKD patients (e.g. in the seminal study of Painter,59 baseline PCS score was 36 AUs). Besides, poor
baseline physical health status is not a reason for lack of response to exercise intervention, because
patients with poorer PCS scores respond better to intervention than those with higher PCS scores.7
Health economic evaluation
The economics evaluation suggests that, over 6 months of implementation, the PEDAL intervention
resulted in higher NHS costs with no gain in QoL as measured by the EQ-5D-5L. A number of factors
should be borne in mind; for example, the benefit from the PEDAL intervention could be avoiding
cardiovascular events and other illnesses in future years, and the 6-month time horizon would not
capture this. In addition, the PEDAL protocol could be refined to target different patients on dialysis
and/or to include a time point at which the benefit of the intervention was assessed with only those
reporting a good QoL gain continuing. Both of these could potentially improve the cost-effectiveness of
the intervention.
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Qualitative analyses of patient views
The explanatory theory developed through the qualitative substudy of the PEDAL trial has provided
in-depth insights into the influences on people’s decision-making relating to participation both in the
trial and in the intervention over time. Themes are supported by the few previous qualitative studies;
however, our data are more extensive, and the resulting theoretical explanation goes further to enable
suggestions for future implementation and intervention sustainability. A novel finding relates to the
importance of culture, and leadership to enable this, in the renal unit. Providers interviewed felt that
the trial did not impinge much on their jobs, which supported trial implementation; however, this may
not be conducive to sustainability of the intervention beyond the trial. Moving forward beyond the
PEDAL trial, it will be most important to influence the attitudes, beliefs and behaviours of providers.
Where providers are engaged and empowered, they are much more likely to engage and empower
patients in participating. Once a patient is participating (where capable), the numerous physical,
functional, psychological and social benefits are likely to support their ongoing participation. This in
itself may then feed forward into a positive, proactive culture in the renal unit. Further research is
needed to explore the complexities of intervention implementation in the longer term, with a view to
aspects of behaviour change and insights from implementation science.
Limitations
The study was designed to assess a pragmatic, clinically implementable intradialytic exercise intervention.
By design, the study relied on a patient-reported outcome measure for its primary outcome; it is
recognised that the primary limitation of this study was the lack of an attention control group. To alleviate
this concern, multiple outcomes were assessed, and objective measures were obtained whenever possible;
only objective measures of habitual physical activity were not of sufficient quality to be presented in this
manuscript (owing to poor patient compliance with wearing accelerometers). In addition, many patients
withdrew from the study (following randomisation but before baseline, and also during follow-up) or were
too unwell to complete all functional capacity and physiological outcome assessments. This particularly
affected the assessments of peak aerobic capacity but is to be expected in a study with inclusive inclusion
criteria and arduous outcome assessments. Finally, the study was not powered to detect differences in
some secondary outcomes, including mortality. Nevertheless, we reported these data to allow a balance of
benefits and harms to be assessed. Future studies should address these concerns by including attention
control groups and being adequately powered to investigate minimal clinically important differences of all
outcome measures. Based on the findings presented herein, studies should address poor compliance by
investigating exercise counselling and behaviour change interventions (such as motivational interviewing
and self-determination theory) and should specifically target ways to overcome complications associated
with concurrent medical events (such as fatigue). Investigators should consider alternative mechanisms
of action of exercise interventions, including self-efficacy and stage of change.43 Finally, the benefits of
including progressive resistance training should be confirmed, even if extradialytic delivery is required.
Conclusion
A pragmatic intradialytic aerobic exercise programme, which could realistically be commissioned as
part of routine care, did not improve QoL of this deconditioned sample of HD patients. The lack of
clinical effectiveness and cost-effectiveness was probably due to poor compliance and only modest
changes in aerobic capacity, particularly in a subgroup of patients with concurrent medical events and
associated fatigue.
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Future work
The benefits of longer interventions, including progressive resistance training, should be confirmed,
even if extradialytic delivery is required. Future studies need to evaluate whether or not there are
subgroups of patients that may benefit from this type of intervention, and also whether or not there
is scope to optimise the exercise intervention to improve compliance and effectiveness. This should
include further qualitative work.
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Patient data
This work uses data provided by patients and collected by the NHS as part of their care and support. Using
patient data is vital to improve health and care for everyone. There is huge potential to make better use of
information from people’s patient records, to understand more about disease, develop new treatments,
monitor safety, and plan NHS services. Patient data should be kept safe and secure, to protect everyone’s
privacy, and it’s important that there are safeguards to make sure that it is stored and used responsibly.
Everyone should be able to find out about how patient data are used. #datasaveslives You can find out
more about the background to this citation here: https://understandingpatientdata.org.uk/data-citation.
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